Data / Research funding / Asthma
Asthma: 820 NIH awards ($1.1B) to 188 organizations
820 NIH awards ($1.1B) in the NIH spending category Asthma, to 188 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 820 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Childhood Asthma in Urban Settings Clinical Research Network - Leadership Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,858,092 | April 12, 2021 | March 31, 2028 | JACKSON, DANIEL J | reporter.nih.gov |
| RhoFED AA-SCCC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $28,163,551 | May 5, 2023 | April 30, 2028 | DAVID, GLORIA | reporter.nih.gov |
| Wisconsin Infant Study Cohort (WISC) ECHO Pediatric Follow-Up | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $26,243,281 | September 21, 2016 | May 31, 2030 | GERN, JAMES E. | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)- COORDINATING CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $15,035,695 | November 30, 2018 | November 29, 2024 | CAI, JIANWEN | reporter.nih.gov |
| Prenatal and Early Childhood Pathways To Health: An Integrated Model of Chemical and Social Exposures, Biological Mechanisms, and Sex-Specific Effects on Neurodevelopment and Respiratory Outcomes | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $14,672,582 | September 21, 2016 | August 31, 2025 | KARR, CATHERINE J | reporter.nih.gov |
| Data, Modeling,and Coordination Center for PrecISE Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $13,407,521 | September 23, 2017 | June 30, 2025 | IVANOVA, ANASTASIA | reporter.nih.gov |
| Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,991,264 | February 8, 2019 | January 31, 2027 | CHAVARRO, JORGE EDUARDO | reporter.nih.gov |
| Immunometabolic phenotypes in adult severe asthma and disease progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $10,501,030 | September 23, 2019 | June 30, 2025 | LEVY, BRUCE D | reporter.nih.gov |
| Penn-CHOP ECHO | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $10,439,338 | September 1, 2023 | May 31, 2025 | MUMFORD, SUNNI L. | reporter.nih.gov |
| Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,604,388 | May 1, 2021 | April 30, 2027 | CAHILL, KATHERINE N | reporter.nih.gov |
| Columbia Center for Children's Environmental Health in ECHO II: Impact of environmental exposures on children's health and the co-morbidity of asthma and ADHD. | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $7,746,645 | September 21, 2016 | May 31, 2025 | HERBSTMAN, JULIE BETH | reporter.nih.gov |
| Interactions Between the Microbiome, Immunity and Respiratory Health in Traditional Agrarian and Suburban children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,471,626 | February 1, 2013 | February 29, 2028 | GERN, JAMES E. | reporter.nih.gov |
| 1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,867,462 | September 15, 2020 | December 15, 2026 | MARTINEZ, FERNANDO D | reporter.nih.gov |
| MIST Early Career Scholar Awards in Mucosal Immunology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,835,591 | July 25, 2011 | June 30, 2026 | ARTIS, DAVID | reporter.nih.gov |
| Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,355,182 | February 1, 2022 | December 31, 2027 | TANTISIRA, KELAN G | reporter.nih.gov |
| Early Origins of Chronic Lung Disease: From Birth to Age 45 Years | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,285,181 | June 1, 2016 | June 30, 2030 | MARTINEZ, FERNANDO D | reporter.nih.gov |
| Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,079,745 | December 15, 2021 | November 30, 2026 | WEESE-MAYER, DEBRA ELLYN | reporter.nih.gov |
| Controlling and preventing Asthma progression and Severity in Kids (CASK) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $5,781,955 | July 20, 2016 | June 30, 2024 | PHIPATANAKUL, WANDA | reporter.nih.gov |
| Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $5,260,253 | September 21, 2016 | August 31, 2024 | WEISS, SCOTT T | reporter.nih.gov |
| Mechanistic clinical trial of blocking the IL-4/13 axis in asthmatics precision phenotyped in an aeroallergen challenge chamber before, during and after receipt of dupilumab | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,232,798 | August 18, 2022 | May 31, 2027 | AHUJA, SUNIL K | reporter.nih.gov |
| Vitamin C to Decrease Effects of Smoking during Pregnancy on Offspring Airway Function, Airway Size, and Epigenetic Correlates: VCSIP cohort follow-up through 10 Years of Age | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,223,986 | August 15, 2023 | May 31, 2028 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,919,940 | April 15, 2019 | June 30, 2026 | ERLE, DAVID J | reporter.nih.gov |
| ASSESSING THE EVOLVING IMPACT OF EARLY LIFE EXPOSURES ON CHILD PHYSICAL HEALTH AND NEURODEVELOPMENT | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $4,873,931 | September 21, 2016 | May 31, 2025 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $4,829,392 | July 15, 2013 | July 31, 2025 | PANETTIERI, REYNOLD ALEXANDER | reporter.nih.gov |
| TIDES III: Endocrine Disruption, Hormones, and Sex Differences in Adolescent Airway Health | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $4,747,443 | May 1, 2015 | May 31, 2027 | SATHYANARAYANA, SHEELA | reporter.nih.gov |
| Neurobiology of the Bronchopulmonary System | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,659,693 | March 1, 2021 | February 28, 2028 | UNDEM, BRADLEY JOEL | reporter.nih.gov |
| Monitoring of disease-induced skin VOC patterns from handheld and wearable chemical sensors | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $4,608,903 | June 22, 2022 | May 31, 2027 | DAVIS, CRISTINA ELIZABETH | reporter.nih.gov |
| Common and distinct early environmental influences on cardiometabolic and respiratory health: Mechanisms and methods | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $4,549,129 | September 21, 2016 | August 31, 2024 | OKEN, EMILY | reporter.nih.gov |
| Controlling and Preventing Asthma Progression and Severity in Kids with Omalizumab Extension (PARK-EXT) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $4,500,000 | July 8, 2024 | April 30, 2029 | PHIPATANAKUL, WANDA | reporter.nih.gov |
| Effect of IL-4RαR576 variant on response to Dupilumab in children with Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,492,892 | April 11, 2019 | March 31, 2026 | PHIPATANAKUL, WANDA | reporter.nih.gov |
| New Approaches for Empowering Studies of Asthma in Populations of African Descent | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $4,384,624 | September 28, 2011 | November 30, 2023 | BARNES, KATHLEEN C | reporter.nih.gov |
| ASSESSING THE EVOLVING IMPACT OF EARLY LIFE EXPOSURES ON CHILD PHYSICAL HEALTH AND NEURODEVELOPMENT | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $4,337,861 | September 21, 2016 | May 31, 2030 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $4,161,751 | September 24, 2018 | July 31, 2025 | SHEPPARD, DEAN | reporter.nih.gov |
| Impact of Sleep Duration on Immune Balance in Urban Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,100,188 | August 15, 2021 | July 31, 2026 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,976,850 | August 15, 2024 | July 31, 2028 | HAMVAS, AARON | reporter.nih.gov |
| Omic Determinants of Longitudinal Lung Function in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,917,165 | June 1, 2021 | May 31, 2027 | MCGEACHIE, MICHAEL JOHN | reporter.nih.gov |
| ECHO II: Impact of environmental exposures on children's health and the co-morbidity of asthma and ADHD | NIH | Office of the Director, National Institutes of Health | 2025 | $3,884,884 | September 21, 2016 | May 31, 2030 | MILLER, RACHEL L | reporter.nih.gov |
| Dissecting the Interoception Circuit that Controls Airway Constriction | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,805,305 | September 1, 2021 | August 31, 2026 | SUN, XIN | reporter.nih.gov |
| Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,542,038 | June 1, 2020 | April 30, 2026 | DAHLIN, AMBER | reporter.nih.gov |
| Control of Pulmonary Inflammation by Leukotriene E4 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,503,395 | August 13, 2021 | July 31, 2026 | BOYCE, JOSHUA A | reporter.nih.gov |
| Environmental Determinants of Sleep Disparities and the Consequences for Low Income Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,496,732 | August 15, 2021 | July 31, 2027 | MCCORMACK, MEREDITH C | reporter.nih.gov |
| ECHO Renewal for the INSPIRE Study Cohort | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $3,488,939 | September 1, 2023 | May 31, 2025 | HARTERT, TINA V | reporter.nih.gov |
| Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,482,387 | February 1, 2022 | January 31, 2027 | DEBLEY, JASON S | reporter.nih.gov |
| Development of SP-A Derived Peptidomimetics for the Treatment of Asthma - Phase II | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $3,433,831 | September 26, 2022 | August 31, 2025 | LEDFORD, JULIE GUNNELLS | reporter.nih.gov |
| Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,411,183 | August 5, 2020 | May 31, 2026 | HALTERMAN, JILL S | reporter.nih.gov |
| Viral and allergen-driven immunity in chronic lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,410,907 | March 1, 2020 | January 31, 2027 | LUKACS, NICHOLAS W | reporter.nih.gov |
| Nasal epithelial epigenomics and transcriptomics and asthma in Hispanic adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,386,733 | June 1, 2021 | May 31, 2027 | CELEDON, JUAN CARLOS | reporter.nih.gov |
| Epigenome-wide variations and socio-environmental exposures in African American asthmatic children | NIH | National Human Genome Research Institute | 2021 to 2025 | $3,355,328 | September 24, 2021 | June 30, 2026 | MERSHA, TESFAYE B. | reporter.nih.gov |
| Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,325,603 | September 24, 2020 | August 31, 2025 | REZNIK, MARINA | reporter.nih.gov |
| Identifying mechanisms and reversibility of eosinophil-induced airway hyperinnervation in asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,251,305 | February 1, 2021 | January 31, 2027 | DRAKE, MATTHEW G. | reporter.nih.gov |
| 3-Dimensional genomic architecture in innate lymphoid cells and allergic inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,226,380 | June 20, 2022 | May 31, 2027 | HENAO-MEJIA, JORGE | reporter.nih.gov |
| Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $3,222,498 | September 21, 2016 | May 31, 2030 | CAMARGO, CARLOS ARTURO | reporter.nih.gov |
| Role of mucin in lung homeostasis and pathophysiology | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,219,550 | August 1, 2009 | April 30, 2027 | EVANS, CHRISTOPHER M | reporter.nih.gov |
| Residential Greenness, Airway Microbiome,and Incident Childhood Asthma | NIH | National Institute of Environmental Health Sciences | 2025 | $3,181,155 | September 18, 2025 | September 17, 2029 | ZHU, ZHAOZHONG | reporter.nih.gov |
| The effect of a housing mobility program on environmental exposures and asthma morbidity | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,169,561 | March 1, 2016 | June 30, 2027 | POLLACK, CRAIG EVAN | reporter.nih.gov |
| Novel Biased Beta2-AR Ligands as Asthma Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,166,566 | March 15, 2021 | February 28, 2027 | WALKER, JULIA K L | reporter.nih.gov |
| Allergen-induced extracellular DNA in type 2 immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,163,994 | September 21, 2022 | July 31, 2027 | KITA, HIROHITO | reporter.nih.gov |
| Immune Development Across the Life Course: Integrating Exposures and Multi-Omics in the Boston Birth Cohort | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $3,158,931 | September 15, 2022 | June 30, 2027 | WANG, XIAOBIN | reporter.nih.gov |
| The Efficacy of CAMP Air, a Web-based Asthma Intervention, Among Urban Adolescents with Uncontrolled Asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,150,671 | July 7, 2021 | June 30, 2027 | BRUZZESE, JEAN-MARIE | reporter.nih.gov |
| Gonadal hormones as mediators of sex and gender influences in asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,148,325 | July 10, 2021 | June 30, 2026 | SILVEYRA, PATRICIA | reporter.nih.gov |
| Precision Approaches to Reduce Asthma Disparities with Electronic Health Record Data | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,142,554 | September 1, 2022 | May 31, 2027 | WEISSMAN, GARY | reporter.nih.gov |
| The ALOHA trial: Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,123,405 | September 20, 2021 | August 31, 2027 | MA, JUN | reporter.nih.gov |
| Mechanisms of Enhanced Neutralizing Antibody Responses to Rhinovirus C | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,122,828 | March 20, 2020 | February 28, 2026 | BOCHKOV, YURY A | reporter.nih.gov |
| Childhood Allergy and the NeOnatal Environment in St Louis (CANOE-STL) and the Impact of Wheezing Illnesses on Neurocognitive Development of Preschool Children | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $3,099,038 | September 1, 2023 | May 31, 2025 | RIVERA-SPOLJARIC, KATHERINE | reporter.nih.gov |
| Integrative Genomics of Acute Asthma Control | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,084,719 | August 6, 2014 | January 31, 2025 | RABY, BENJAMIN ALEXANDER | reporter.nih.gov |
| Discovery of Gene-by-Air Pollution Interactions in Respiratory Disease using Genetically Diverse Mice with Validation in Humans | NIH | National Institute of Environmental Health Sciences | 2025 | $3,082,011 | September 19, 2025 | September 18, 2029 | KELADA, SAMIR | reporter.nih.gov |
| Reducing Asthma Attacks in Disadvantaged School Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,049,831 | September 10, 2020 | August 31, 2027 | SZEFLER, STANLEY J. | reporter.nih.gov |
| Eicosanoid Networks in Aspirin Hypersensitivity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,049,346 | December 4, 2017 | November 30, 2027 | BOYCE, JOSHUA A | reporter.nih.gov |
| Targeting lipid rafts for treatment of asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,043,597 | June 20, 2019 | March 31, 2027 | KOGAN, YAKOV | reporter.nih.gov |
| Role of TNF receptor 2 on Pulmonary Group 2 Innate Lymphoid Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,029,887 | December 15, 2021 | November 30, 2026 | AKBARI, OMID | reporter.nih.gov |
| Implementation of a multilevel program to reduce asthma symptoms in urban preschoolers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,015,744 | August 1, 2020 | July 31, 2025 | EAKIN, MICHELLE NUTTALL | reporter.nih.gov |
| The Effects of Accountable Care Organizations on Disparities in Childhood Asthma Care and Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,996,224 | May 15, 2021 | February 28, 2027 | GOFF, SARAH L | reporter.nih.gov |
| Understanding Mechanisms Underlying Chronic Stress-Induced Asthma in Children by Population and Single-Cell Epigenomics Approaches | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,991,102 | August 26, 2020 | April 30, 2026 | GRUNDBERG, ELIN | reporter.nih.gov |
| Antigenic determinants of asthma-associated allergens for design of immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,974,640 | August 25, 2009 | August 31, 2030 | POMES, ANNA | reporter.nih.gov |
| Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,954,211 | April 15, 2012 | February 28, 2027 | GERBER, ANTHONY N | reporter.nih.gov |
| A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,952,468 | May 1, 2020 | June 30, 2025 | FANGER, NEIL A | reporter.nih.gov |
| Mold Policy Intervention in New York City Public Housing and Asthma Morbidity | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,948,318 | September 10, 2021 | June 30, 2027 | PERZANOWSKI, MATTHEW S | reporter.nih.gov |
| Specialized Pro-Resolving Mediators in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,944,770 | May 20, 2014 | May 31, 2026 | LEVY, BRUCE D | reporter.nih.gov |
| Mechanisms of IL-33 secretion in allergic diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,942,746 | December 16, 2016 | January 31, 2027 | KITA, HIROHITO | reporter.nih.gov |
| Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,921,132 | February 4, 2022 | April 30, 2025 | VALLADARES, RICARDO | reporter.nih.gov |
| Origin and Function of Intra-epithelial Mast Cells in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,919,325 | April 1, 2021 | March 31, 2026 | HALLSTRAND, TEAL S | reporter.nih.gov |
| Study the link of autophagy dysfunction to allergic and neutrophilic asthma onset | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,911,118 | July 1, 2020 | June 30, 2026 | AKBARI, OMID | reporter.nih.gov |
| Parkin in mitochondrial dysfunction and airway inflammation of obese asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,892,074 | September 16, 2020 | August 31, 2025 | CHU, HONG W | reporter.nih.gov |
| Deep Functional Phenotyping of the ALA Lung Health Cohort | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,888,675 | August 15, 2022 | July 31, 2027 | IRVIN, CHARLES G | reporter.nih.gov |
| Genomics and Pharmacogenomics of Symptoms in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,880,791 | September 27, 2011 | May 31, 2026 | TANTISIRA, KELAN G | reporter.nih.gov |
| Epigenomics of asthma risk factors and clinical subtypes in minority children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,872,208 | January 1, 2021 | November 30, 2025 | ZIV, ELAD | reporter.nih.gov |
| Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,856,749 | May 10, 2021 | February 28, 2027 | PARK, GYE YOUNG | reporter.nih.gov |
| Childhood Allergy and the NeOnatal Environment (CANOE) ECHO Pediatric Follow-Up and New Enrollment | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,848,939 | September 1, 2023 | May 31, 2025 | SINGH, ANNE MARIE | reporter.nih.gov |
| Wearable, Always-on Stethoscope for Early Detection of Asthma Attack | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,810,319 | August 1, 2022 | July 31, 2027 | KIM, EUN SOK | reporter.nih.gov |
| Puerto Rico Asthma Integrated Response Program (PR-AIR) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,807,566 | September 15, 2022 | July 31, 2027 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Allergic inflammation and Transcriptional Regulation in Th9 cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,806,536 | March 15, 2005 | April 30, 2026 | KAPLAN, MARK H | reporter.nih.gov |
| A Coping Skills Intervention for Low-SES Latino Families of Children with Asthma | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,785,399 | September 18, 2020 | March 28, 2025 | RODRIGUEZ, ERIN M. | reporter.nih.gov |
| S-glutathionylation chemistry in fibrotic lung remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,783,548 | January 1, 2017 | December 31, 2023 | JANSSEN-HEININGER, YVONNE M. W. | reporter.nih.gov |
| Systems Biology of a MicroRNA Network in Neutrophilic Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,771,837 | July 1, 2020 | June 30, 2026 | GOMEZ-VILLALOBOS, JOSE LUIS | reporter.nih.gov |
| AIM2ACT: A Mobile Health Tool to Facilitate Asthma Self-Management during Early Adolescence | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,771,442 | June 10, 2020 | May 31, 2026 | PRABHAKARAN, SREEKALA SPRABHAKARAN | reporter.nih.gov |
| ACTION, A lifestyle physiCal acTivity Intervention for MinOrity womeN with asthma: From Efficacy to Implementation | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,764,358 | August 7, 2022 | April 30, 2027 | NYENHUIS, SHARMILEE MARIA | reporter.nih.gov |
| ECHO Renewal for the CANOE Study Cohort | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,735,209 | September 1, 2023 | May 31, 2026 | HARTERT, TINA V | reporter.nih.gov |
| Androgens inhibit IL-33 production and airway inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,734,795 | December 22, 2014 | February 28, 2026 | NEWCOMB, DAWN C | reporter.nih.gov |
| Mechanisms of Allergen-induced Type 2 Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,733,347 | November 1, 2019 | April 30, 2028 | KITA, HIROHITO | reporter.nih.gov |
| The Hospital to Home Study: A Pragmatic Trial to Optimize Transitions and Address Disparities in Asthma Care | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,705,778 | January 1, 2023 | December 31, 2027 | PARIKH, KAVITA | reporter.nih.gov |
| Integrative Metabolomics of Asthma Severity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,684,304 | August 1, 2014 | May 31, 2025 | LASKY-SU, JESSICA A | reporter.nih.gov |
| Neonatal Modulation of Airway Contractility | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,678,361 | May 3, 1996 | May 31, 2027 | PRAKASH, Y. S. | reporter.nih.gov |
| Psychosocial and Genetic Effects on Gene Expression and Asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,663,458 | March 15, 2022 | December 31, 2026 | PIQUE-REGI, ROGER | reporter.nih.gov |
| Phenotypic and biological features of mucus plugs in asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,637,630 | July 1, 2005 | April 30, 2027 | FAHY, JOHN V | reporter.nih.gov |
| Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,637,259 | August 22, 2022 | May 31, 2027 | FAHY, JOHN V | reporter.nih.gov |
| Lung-specific expression and function of Blimp-1 in T cells impacting allergic asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,631,349 | April 14, 2021 | November 30, 2026 | POHOLEK, AMANDA CATHERINE | reporter.nih.gov |
| Genetic and Epigenetic Programming of Allergic Airway Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,629,183 | August 1, 1998 | January 31, 2028 | CHATILA, TALAL AMINE | reporter.nih.gov |
| Defining mechanisms of CC16 on epithelial-driven host responses to pathogens | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,607,906 | September 1, 2019 | June 30, 2028 | LEDFORD, JULIE GUNNELLS | reporter.nih.gov |
| Prostaglandin E2-Dependent Control of a Mast Cell IL-33/ST2 Pathway in Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,578,983 | April 1, 2023 | March 31, 2028 | BOYCE, JOSHUA A | reporter.nih.gov |
| BREATHE: An efficacy-implementation trial of a brief shared decision making intervention among Black adults with uncontrolled Asthma in Federally Qualified Health Centers (FQHC). | NIH | National Institute of Nursing Research | 2021 to 2025 | $2,568,179 | May 6, 2021 | February 28, 2027 | GEORGE, MAUREEN | reporter.nih.gov |
| Respiratory sphingolipid synthesis involved in airway hyperreactivity and viral-triggered asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,566,220 | February 8, 2023 | January 31, 2028 | WORGALL, STEFAN | reporter.nih.gov |
| Disparities in Sleep, Asthma, and the Sleep Context in Urban Children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,538,179 | May 24, 2019 | April 30, 2025 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Cellular Senescence in Neonatal Airways | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,503,972 | July 1, 2022 | June 30, 2027 | PRAKASH, Y. S. | reporter.nih.gov |
| Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,486,633 | December 1, 2021 | July 31, 2022 | PANETTIERI, REYNOLD ALEXANDER | reporter.nih.gov |
| EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,481,810 | September 12, 2023 | May 31, 2028 | CHRISTENSON, STEPHANIE A | reporter.nih.gov |
| Inhalation Repurposing of An Approved Drug to Treat Severe Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,462,600 | January 9, 2021 | December 31, 2024 | SULLIVAN, JOHN | reporter.nih.gov |
| Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,456,715 | May 18, 2021 | April 30, 2027 | YANG, KAI | reporter.nih.gov |
| DNA induction of neutrophilic asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,455,981 | September 17, 2021 | August 31, 2026 | ALAM, RAFEUL | reporter.nih.gov |
| Airway Structural Cells and Corticosteroid Resistance in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,450,257 | December 20, 2020 | November 30, 2026 | BRITT, RODNEY | reporter.nih.gov |
| Asthma susceptibility due to environmental programming of innate immunity in utero | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,448,755 | January 1, 2015 | November 30, 2025 | GORSKA, MAGDALENA MARIA | reporter.nih.gov |
| ILC2 memory in asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,440,552 | September 21, 2020 | August 31, 2025 | ALAM, RAFEUL | reporter.nih.gov |
| Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,408,222 | July 1, 2023 | June 30, 2028 | WORGALL, STEFAN | reporter.nih.gov |
| Immunopathogenesis in fungal asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,385,748 | December 8, 2014 | February 29, 2028 | STEELE, CHAD | reporter.nih.gov |
| Allergen-specific lung-resident Tregs in asthma: Targetable suppressors of resident memory Th2 cells | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,382,811 | February 4, 2022 | January 31, 2027 | LUSTER, ANDREW D | reporter.nih.gov |
| Targeting T cell glutamine metabolism in severe asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,375,946 | April 6, 2017 | May 31, 2026 | RATHMELL, JEFFREY C. | reporter.nih.gov |
| Mechanisms of airway hyperresponsiveness in the offspring of obese mothers | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,365,910 | June 15, 2022 | April 30, 2027 | NIE, ZHENYING | reporter.nih.gov |
| The SIP Study: Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,345,953 | July 5, 2022 | June 30, 2026 | KAISER, SUNITHA VEMULA | reporter.nih.gov |
| Clinic navigation and home visits to improve guideline-based care and outcomes in low income minority adults with asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,316,981 | June 1, 2019 | October 31, 2025 | APTER, ANDREA J. | reporter.nih.gov |
| Prenatal and lifetime exposure to pesticides and particulate matter and respiratory health in young adults from the CHAMACOS birth | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,306,178 | February 10, 2022 | November 30, 2026 | GUNIER, ROBERT | reporter.nih.gov |
| CAUSE Clinical Research Center New York (CAUSE-CRC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,295,803 | April 22, 2021 | March 31, 2028 | KATTAN, MEYER | reporter.nih.gov |
| Wood Pellet Emissions and Children's Environmental Health in Mississippi | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $2,292,950 | August 6, 2024 | May 31, 2029 | WALKER, ERICA | reporter.nih.gov |
| A Cul5 E3 ubiquitin ligase complex that prevents allergic asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,292,339 | May 18, 2020 | January 31, 2026 | OLIVER, PAULA MARIA | reporter.nih.gov |
| Regulation of Allergen-Induced Airway Pathophysiology by Versican | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,288,169 | February 2, 2019 | January 31, 2025 | FREVERT, CHARLES WAYNE | reporter.nih.gov |
| Soy Isoflavones for Inner City Infants at Risk for Asthma (SIRA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,286,643 | April 14, 2021 | March 31, 2028 | KUMAR, RAJESH | reporter.nih.gov |
| LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,285,261 | May 1, 2022 | April 30, 2027 | HOLGUIN, FERNANDO | reporter.nih.gov |
| A Novel ENaC Blocker/Osmolyte Inhalation Solution for the Treatment of Muco-Obstructive Lung Diseases | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,267,449 | August 15, 2025 | July 31, 2027 | DONN, KARL H | reporter.nih.gov |
| Asthma Link: A Partnership between Pediatric Practices, Schools, and Families to Improve Medication Adherence and Health Outcomes in Children with Poorly Controlled Asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,263,433 | August 15, 2023 | May 31, 2028 | TRIVEDI, MICHELLE | reporter.nih.gov |
| Investigating the mechanisms by which systemic inflammation promotes Alzheimer’s disease: Asthma as a model and modifiable risk factor | NIH | National Institute on Aging | 2023 | $2,261,120 | June 1, 2023 | May 31, 2026 | ROSENKRANZ, MELISSA A | reporter.nih.gov |
| Multi-omics of the Frequent Exacerbator Asthmatic | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,260,000 | April 9, 2021 | March 31, 2028 | KHURANA HERSHEY, GURJIT K. | reporter.nih.gov |
| A Randomized Controlled Trial of Home Air Purification for Eosinophilic COPD | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,257,861 | May 15, 2020 | September 30, 2024 | RICE, MARY B | reporter.nih.gov |
| Chromosome 17q21, allergic inflammation, and remodeling | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,250,509 | May 15, 2013 | February 28, 2026 | BROIDE, DAVID H | reporter.nih.gov |
| Predicting Exacerbations of Asthma in Real-World Patients with Low Medical Utilization (PEARL) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,249,367 | February 21, 2023 | December 31, 2027 | CHEN, WANSU | reporter.nih.gov |
| Epigenetic mechanisms of inflammatory memory propagation in human airway epithelia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,249,254 | May 5, 2022 | January 31, 2027 | PEZZULO, ALEJANDRO ANTONIO | reporter.nih.gov |
| Mechanisms of Nanoparticle Modulation of Allergic Lung Disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,246,746 | September 1, 2021 | June 30, 2027 | BONNER, JAMES CHRISTOPHER | reporter.nih.gov |
| Children's Allergy and Asthma Data Repository (CADRE) Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,246,640 | August 6, 2024 | May 31, 2029 | GERN, JAMES E. | reporter.nih.gov |
| Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,236,725 | August 15, 2020 | June 30, 2025 | QUE, LORETTA G | reporter.nih.gov |
| G Protein-Coupled Receptor Regulation in Airway Myocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,231,563 | August 1, 1997 | July 31, 2028 | PENN, RAYMOND B. | reporter.nih.gov |
| Role of immunoproteasome in airway viral infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,230,937 | May 1, 2020 | April 30, 2026 | CHU, HONG W | reporter.nih.gov |
| Dysregulated Immunometabolism and Premature Senescence in Corticosteroid-Refractory Severe Asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,209,066 | February 1, 2023 | January 31, 2030 | RAY, ANURADHA | reporter.nih.gov |
| Associations among maternal lifetime psychosocial stress, prenatal systemic and placental oxidative stress mixtures, and child asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,204,305 | April 20, 2023 | February 28, 2027 | CARROLL, KECIA NICOLE | reporter.nih.gov |
| Age-related mechanisms of T helper 2 memory in the early lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,199,759 | July 9, 2021 | June 30, 2026 | AI, XINGBIN | reporter.nih.gov |
| Non-Classical Cytokine Secretion in Chronic Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,192,673 | July 1, 2020 | June 30, 2026 | ALEXANDER-BRETT, JENNIFER | reporter.nih.gov |
| Indoor Air Quality and Respiratory Morbidity in School-Aged Children with Bronchopulmonary Dysplasia | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,182,320 | January 15, 2019 | June 30, 2025 | GAFFIN, JONATHAN MARK | reporter.nih.gov |
| Functional role of miR-511-3p in allergic asthma and its underlying mechanisms | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,176,815 | April 7, 2021 | March 31, 2027 | GAO, PEISONG | reporter.nih.gov |
| Characterization of biased airway smooth muscle TAS2R agonists for treating asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,168,714 | January 1, 2021 | December 31, 2025 | LIGGETT, STEPHEN B | reporter.nih.gov |
| Childhood Asthma in Urban Settings | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,163,187 | April 15, 2021 | March 31, 2028 | BUSSE, PAULA J | reporter.nih.gov |
| Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,162,793 | July 15, 2021 | July 31, 2027 | EAKIN, MICHELLE NUTTALL | reporter.nih.gov |
| Rhode Island Child Clinical Trials Collaborative | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $2,159,647 | September 23, 2016 | May 31, 2030 | CHUN, THOMAS H | reporter.nih.gov |
| The school microbiome and asthma morbidity in inner-city children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,152,695 | January 1, 2019 | December 31, 2025 | LAI, PEGGY SUE | reporter.nih.gov |
| Reducing Asthma Attacks in Disadvantaged School Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,140,540 | September 10, 2020 | August 31, 2023 | SZEFLER, STANLEY J. | reporter.nih.gov |
| Improving Pediatric Access to Clinical Trials in Vermont (IMPACT VT) | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $2,130,442 | September 23, 2016 | May 31, 2030 | COWAN, KELLY JEAN | reporter.nih.gov |
| District of Columbia Childhood Asthma in Urban Settings - Clinical Research Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,111,444 | April 15, 2021 | March 31, 2028 | SHEEHAN, WILLIAM JAMES | reporter.nih.gov |
| SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,104,711 | July 1, 2019 | June 30, 2025 | HOLGUIN, FERNANDO | reporter.nih.gov |
| Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,083,062 | February 1, 2023 | January 31, 2028 | TEAGUE, WILLIAM GERALD | reporter.nih.gov |
| Mucin sialylation drives epithelial cell senescence and severe asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,081,476 | July 1, 2020 | June 30, 2025 | WENZEL, SALLY E | reporter.nih.gov |
| Fungal Asthma and Lung Innate Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,070,324 | May 7, 2020 | April 30, 2026 | CHEN, YIN | reporter.nih.gov |
| Identifying pediatric asthma subtypes using novel privacy-preserving federated machine learning methods | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,046,907 | September 1, 2023 | June 30, 2028 | FISHE, JENNIFER NOEL | reporter.nih.gov |
| Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,045,450 | February 10, 2019 | January 31, 2026 | BRASIER, ALLAN R. | reporter.nih.gov |
| Microbiome in Asthma Induced by Environmental Particle Exposure | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,038,678 | April 2, 2019 | January 31, 2025 | GONZALEZ-JUARBE, NORBERTO | reporter.nih.gov |
| A New Small-Molecule Kinase Inhibitor for Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,038,199 | August 7, 2019 | June 30, 2027 | BROSCHAT, KAY O | reporter.nih.gov |
| Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,031,214 | February 1, 2023 | June 30, 2027 | ZHANG, KE | reporter.nih.gov |
| Exposure to violence during childhood and Th2-high asthma in young Puerto Rican adults | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,030,987 | July 1, 2023 | March 31, 2028 | CELEDON, JUAN CARLOS | reporter.nih.gov |
| Novel NOTCH4 Pathway of Asthma Severity in Urban School Children: Clinical Research Center, Boston Children’s Hospital | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,024,001 | April 13, 2021 | March 31, 2028 | PHIPATANAKUL, WANDA | reporter.nih.gov |
| Primary care Implementation and evaluation of Coach McLungs™ an asthma shared decision-making intervention, across a large healthcare system | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,018,590 | September 1, 2021 | July 31, 2027 | TAPP, HAZEL | reporter.nih.gov |
| Telehealth-Enhanced Asthma Care for Home after the Emergency Room (TEACH-ER) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,011,425 | September 15, 2023 | June 30, 2028 | FREY, SEAN MICHAEL | reporter.nih.gov |
| Mechanism of Transcriptional Regulation of Th2 Cell Development | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,008,941 | June 9, 2023 | May 31, 2028 | ZHOU, MING-MING | reporter.nih.gov |
| An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,004,943 | August 15, 2017 | June 30, 2025 | BENDER, BRUCE GEORGE | reporter.nih.gov |
| 2/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,997,251 | September 15, 2020 | November 15, 2026 | CASPER, THERON C | reporter.nih.gov |
| Project ASTHMA – Aligning with Schools To Help Manage Asthma and Improve Outcomes | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,966,010 | September 24, 2023 | April 30, 2028 | HOLMES, LUCY | reporter.nih.gov |
| Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,965,911 | June 22, 2021 | November 9, 2023 | ROTHSTEIN, JAY L | reporter.nih.gov |
| Symptom clusters in children with exacerbation-prone asthma | NIH | National Institute of Nursing Research | 2021 to 2023 | $1,959,562 | September 10, 2019 | June 30, 2025 | FITZPATRICK, ANNE MENTRO | reporter.nih.gov |
| Redeveloping Low-Income Communities Of Color: Impacts On Residents' Obesity And Related Health Behaviors | NIH | National Cancer Institute | 2023 to 2025 | $1,958,889 | June 1, 2023 | August 31, 2028 | SHIER, VICTORIA | reporter.nih.gov |
| Mitochondrial translocator protein: a target for bronchodilation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,957,445 | July 1, 2021 | June 30, 2027 | NAYAK, AJAY | reporter.nih.gov |
| VEGF/KDR Signaling in Airway Epithelial Regeneration and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,957,240 | March 1, 2021 | February 28, 2026 | QUE, JIANWEN | reporter.nih.gov |
| A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,944,774 | June 5, 2020 | May 31, 2026 | JONES, BRIDGETTE L. | reporter.nih.gov |
| Maternal programming of the stem cell-basophil axis for asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,932,227 | July 20, 2020 | June 30, 2025 | GORSKA, MAGDALENA MARIA | reporter.nih.gov |
| PLK1 Regulation of Airway Smooth Muscle | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,924,839 | July 1, 2016 | March 31, 2026 | TANG, DALE D. | reporter.nih.gov |
| Central Nervous System Plasticity in Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,900,633 | January 1, 2021 | November 30, 2026 | REZNIKOV, LEAH R | reporter.nih.gov |
| Infant blood epigenome and risks of IgE sensitization, obesity, and asthma: MARC-35/43 cohorts | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,887,257 | August 13, 2020 | July 31, 2025 | LIANG, LIMING | reporter.nih.gov |
| Reducing Airway Smooth Muscle Tone Using Inhaled Statins | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,862,596 | May 15, 2020 | April 30, 2026 | ZEKI, AMIR A. | reporter.nih.gov |
| P2X3 is a Female-Dominant Amplifier of Mast Cell Function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,849,960 | August 1, 2021 | July 31, 2027 | RYAN, JOHN J | reporter.nih.gov |
| Insulin increases nerve-mediated bronchoconstriction in obesity-related asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,843,950 | December 1, 2022 | November 30, 2026 | NIE, ZHENYING | reporter.nih.gov |
| TRP Channels and Air Pollution | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $1,841,549 | September 17, 2009 | June 30, 2026 | REILLY, CHRISTOPHER A | reporter.nih.gov |
| Ultrafine Particulate Monitor for Personal Exposure Assessment | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $1,839,486 | January 1, 2019 | June 30, 2024 | WOOLSEY, DAVID MICHAEL | reporter.nih.gov |
| Circadian Signatures in Chronic Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,833,797 | August 1, 2020 | May 31, 2025 | HASPEL, JEFFREY ADAM | reporter.nih.gov |
| IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,831,890 | January 3, 2019 | December 31, 2025 | KEEGAN, ACHSAH D. | reporter.nih.gov |
| Neurogenic Inflammatory Response to RSV | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,831,459 | July 1, 1999 | June 30, 2025 | PIEDIMONTE, GIOVANNI | reporter.nih.gov |
| Development of B cell memory in allergic asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,808,134 | June 15, 2022 | April 30, 2027 | WU, YEE LING | reporter.nih.gov |
| Positive Affect and Pediatric Asthma: An Innovative Positive Psychology Model to Improve Asthma Management and Health | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,804,772 | September 1, 2023 | May 31, 2028 | JENKINS, BROOKE | reporter.nih.gov |
| Regulation of cellular functions by the plasminogen receptor, Plg-RKT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,800,000 | April 6, 2007 | March 31, 2025 | MILES, LINDSEY A | reporter.nih.gov |
| MicroRNA directed pathway discovery in allergy and asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,799,919 | August 1, 2011 | February 28, 2029 | ANSEL, KARL MARK | reporter.nih.gov |
| Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Data Coordinating Center (ALPS FS - DCC) | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,795,125 | August 5, 2010 | July 31, 2024 | CLIFTON, REBECCA GERSNOVIEZ | reporter.nih.gov |
| Hydrogen Sulfide in Neonatal Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,792,104 | January 1, 2023 | November 30, 2026 | PABELICK, CHRISTINA MARIA | reporter.nih.gov |
| Using statistical network methods to elucidate the multi-omic modulators of the effect of maternal vitamin D levels on childhood asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,789,473 | December 1, 2023 | November 30, 2028 | HALU, ARDA | reporter.nih.gov |
| Impact of Obesity on Lung Macrophage Metabolism and Inflammation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,784,516 | December 15, 2022 | November 30, 2027 | HILL, DAVID ANDREW | reporter.nih.gov |
| Regulation of T cell responses to allergens and environmental microbes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,782,000 | February 10, 2015 | January 31, 2025 | LUND, FRANCES E. | reporter.nih.gov |
| Early Life Rhinovirus Infection and Childhood Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,780,389 | July 3, 2015 | June 30, 2026 | HERSHENSON, MARC B. | reporter.nih.gov |
| Kisspeptins in the Airway | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,775,384 | March 5, 2020 | February 28, 2026 | VENKATACHALEM, SATHISH | reporter.nih.gov |
| Role of TET1 in airway epithelium and childhood asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,772,929 | May 20, 2019 | April 30, 2025 | JI, HONG | reporter.nih.gov |
| tRNA-derived non-coding RNAs in ASM function and in asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,764,249 | July 1, 2020 | June 30, 2025 | KIRINO, YOHEI | reporter.nih.gov |
| Rhode Island Asthma Integrated Response Program (RI-AIR) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,761,713 | August 15, 2017 | June 30, 2025 | MCQUAID, ELIZABETH L | reporter.nih.gov |
| Airway dual-transcriptomics in bronchiolitis and risk of asthma: MARC-35 cohort | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,759,137 | February 14, 2018 | January 31, 2024 | HASEGAWA, KOHEI | reporter.nih.gov |
| Diacylglycerol kinase in airway smooth muscle functions | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,755,123 | April 1, 2019 | June 30, 2028 | DESHPANDE, DEEPAK A | reporter.nih.gov |
| Metabolic perturbations in conventional dendritic cells modulate Tfh13 induction in asthmatic sensitization | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,748,696 | December 25, 2022 | November 30, 2027 | MARTIN, REBECCA KELLEY | reporter.nih.gov |
| Factors Influencing Pediatric Asthma into Adulthood (FIPA2) | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,740,885 | September 25, 2023 | April 30, 2028 | BEST, LYLE G | reporter.nih.gov |
| Immune Mediators of IL-22 Signaling Alter Allergic Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,734,558 | March 1, 2020 | February 28, 2026 | MANNI, MICHELLE LYNN | reporter.nih.gov |
| Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,732,792 | April 1, 2020 | March 31, 2025 | WENZEL, SALLY E | reporter.nih.gov |
| Environmental Pollutants Potentiate Allergic Inflammation via Functional Axis of Aryl hydrocarbon Receptor, ROS, and CaMKII in Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,732,227 | June 19, 2019 | May 31, 2026 | GAO, PEISONG | reporter.nih.gov |
| Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,722,576 | February 15, 2020 | June 30, 2024 | REED, MATTHEW | reporter.nih.gov |
| Asthma Exacerbations and MicroRNA prediction: Treatment Response in an Underserved Ethnicity (AEM-TRUE) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,717,119 | January 15, 2018 | December 31, 2024 | MCGEACHIE, MICHAEL JOHN | reporter.nih.gov |
| Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $1,707,530 | September 21, 2016 | May 31, 2025 | CAMARGO, CARLOS ARTURO | reporter.nih.gov |
| West Philadelphia Asthma Care Implementation Plan | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,705,973 | August 15, 2017 | June 30, 2025 | BRYANT-STEPHENS, TYRA C | reporter.nih.gov |
| Communicating Lung Dysfunction to the Brain in Alzheimer's Disease | NIH | National Institute on Aging | 2023 | $1,703,626 | September 1, 2023 | August 31, 2026 | COMBS, COLIN K | reporter.nih.gov |
| Urban planning, siting of air pollution sources, and asthma disparities | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,698,308 | January 27, 2023 | October 31, 2027 | MATSUI, ELIZABETH C. | reporter.nih.gov |
| E-Cigarette Vaping during Pregnancy and Lactation, Germ Cell Epigenetic Memory, and Transgenerational Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,694,775 | June 1, 2020 | May 31, 2025 | REHAN, VIRENDER K | reporter.nih.gov |
| Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,691,223 | January 1, 2023 | November 30, 2026 | KEENAN, KATHRYN ELIZABETH | reporter.nih.gov |
| Models of rhinovirus-C respiratory infection and asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,688,252 | September 22, 2020 | August 31, 2025 | HERSHENSON, MARC B. | reporter.nih.gov |
| Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,684,565 | April 21, 2021 | March 31, 2028 | LIU, ANDREW H | reporter.nih.gov |
| Compartmentalized signaling and crosstalk in airway myocytes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,679,664 | July 1, 2023 | June 30, 2027 | RICH, THOMAS C | reporter.nih.gov |
| Epidemiology of multimorbid pediatric atopic and airway diseases and the impact of prenatal maternal environmental exposures and placental epigenetics | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $1,677,190 | September 1, 2023 | May 31, 2025 | STRAUGHEN, JENNIFER K. | reporter.nih.gov |
| Elucidation of the regulation and function of innate lymphoid cells | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,675,534 | August 1, 2020 | July 31, 2025 | HUANG, YUEFENG | reporter.nih.gov |
| Pharmacokinetic and Efficacy Studies of the Aerosolized PAR2 Antagonist, C781, for the Treatment of Asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,671,055 | September 1, 2021 | August 31, 2026 | DEFEA, KATHRYN ANNE | reporter.nih.gov |
| Targeting T2 inflammation-evoked mechanical endotypes of ASM shortening in asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,669,921 | June 25, 2023 | March 31, 2027 | AN, STEVEN S | reporter.nih.gov |
| Effect of infant antibiotics on the development of the early-life airway and gut microbiome and risk of childhood asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,668,386 | September 15, 2024 | June 30, 2029 | ROSAS-SALAZAR, CHRISTIAN | reporter.nih.gov |
| Function and regulation of mucosal associated invariant T cells in the lung | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,658,676 | November 24, 2021 | June 30, 2027 | YANG, QI | reporter.nih.gov |
| Transcriptional and metabolomic regulation of IL-10 in pulmonary ILC2s | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,650,000 | September 20, 2022 | July 31, 2027 | AKBARI, OMID | reporter.nih.gov |
| Depression in Older Asthmatics: Understanding Inflammatory and Behavioral Pathways | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,645,945 | June 1, 2019 | April 30, 2024 | WISNIVESKY, JUAN P | reporter.nih.gov |
| Innate immune regulation of lung inflammation through mitochondrial dynamics | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,618,992 | May 2, 2023 | April 30, 2027 | MONTICELLI, LAUREL ANNE | reporter.nih.gov |
| Understanding alterations to mucus composition and function in asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,614,918 | July 1, 2022 | April 30, 2027 | DUNCAN, GREGG | reporter.nih.gov |
| Dectin-1 Signaling Mechanisms | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,599,798 | January 1, 2008 | May 31, 2025 | UNDERHILL, DAVID M. | reporter.nih.gov |
| Solitary chemosensory / tuft cells in lung regeneration and inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,597,401 | June 1, 2020 | May 31, 2025 | VAUGHAN, ANDREW | reporter.nih.gov |
| Maternal trauma, circulating microRNA in extracellular vesicles, and programming of childhood respiratory outcomes | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $1,586,318 | September 18, 2018 | May 31, 2025 | LEE, ALISON G | reporter.nih.gov |
| Identification and characterization of children with asthma-associated comorbidities through computational and immune phenotyping | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,584,833 | April 1, 2015 | January 31, 2025 | JUHN, YOUNG J | reporter.nih.gov |
| The Airway Functional Genomics of Bronchodilator Drug Response in Minority Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,579,724 | August 1, 2013 | June 30, 2024 | ZIV, ELAD | reporter.nih.gov |
| Role of Cytosolic DNA-multiprotein Interactome in Allergic Airway Inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,579,503 | January 10, 2019 | December 31, 2024 | HAZRA, TAPAS K | reporter.nih.gov |
| Mapping Airway Epithelial Cell-Immune Cell Interactions in Lung Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,579,374 | September 1, 2024 | August 31, 2029 | MEDOFF, BENJAMIN DAVID | reporter.nih.gov |
| Development of allergy in offspring is enhanced by maternal eicosanoids and lung microbiota composition dysbiosis. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,567,858 | November 8, 2023 | October 31, 2028 | COOK-MILLS, JOAN M | reporter.nih.gov |
| IMPROVE 2: Inhaled Mometasone to Promote Reduction in Vaso-occlusive Events | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,567,821 | August 1, 2018 | June 30, 2024 | GLASSBERG, JEFFREY AVINS | reporter.nih.gov |
| Single Maintenance And Reliever Therapy Strategies for Implementation and Effectiveness Trial | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,566,987 | September 17, 2024 | June 30, 2028 | KENYON, CHEN COLLIN | reporter.nih.gov |
| Action towards health equity and improved air quality in the Duwamish Valley: A multilevel asthma intervention | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,554,155 | February 6, 2023 | November 30, 2027 | HAJAT, ANJUM | reporter.nih.gov |
| FOXP3 ΔE2 isoform in asthma severity and persistence | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,553,924 | June 4, 2024 | April 30, 2029 | ZHOU, BAOHUA | reporter.nih.gov |
| The circadian clock as an age sensor in asthma resolution | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,552,324 | September 15, 2024 | June 30, 2028 | HASPEL, JEFFREY ADAM | reporter.nih.gov |
| Better utilization of omics data to inform precision medicine for asthma throughout the life course | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,551,459 | March 15, 2024 | January 31, 2028 | LASKY-SU, JESSICA A | reporter.nih.gov |
| Hyperpolarized xenon MRI in treatment of severe asthma by mepolizumab: toward earlier detection of individual patient responses | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,550,000 | June 1, 2020 | April 30, 2026 | THOMEN, ROBERT PAUL | reporter.nih.gov |
| Childhood Allergy and the NeOnatal Environment (CANOE) ECHO Pediatric Follow-Up and New Enrollment | NIH | Office of the Director, National Institutes of Health | 2025 | $1,549,446 | September 1, 2023 | May 31, 2030 | SINGH, ANNE MARIE | reporter.nih.gov |
| Mitochondrial Redox Perturbations in Obese Allergic Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,548,027 | September 7, 2018 | July 31, 2025 | DIXON, ANNE E | reporter.nih.gov |
| Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,547,487 | June 1, 2024 | May 31, 2028 | WU, PINGSHENG | reporter.nih.gov |
| Mechanisms of tachykinergic nerve-mediated severe bronchoconstriction and inflammation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,545,233 | June 15, 2024 | March 31, 2028 | DRAKE, MATTHEW G. | reporter.nih.gov |
| Molecular Mechanisms for Resolving Air Pollution Induced Pulmonary Inflammation: Potential Differences by Asthma and Sex (RAPIDAS) | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,542,500 | September 1, 2023 | June 30, 2028 | ZHANG, JUNFENG | reporter.nih.gov |
| The TNF Superfamily Control of Pathological Remodeling Associated with Severe Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,538,592 | June 1, 2023 | May 31, 2028 | HERRO, RANA ELIAS | reporter.nih.gov |
| Cell surface LMAN1 as a General Sensor and Negative Regulator of Mannosylated Aeroallergens | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,527,514 | July 1, 2022 | April 30, 2027 | TIGNO-ARANJUEZ, JUSTINE TIGLAO | reporter.nih.gov |
| A randomized trial of perception of airflow limitation training to improve outcomes for older adults with asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,524,694 | December 22, 2023 | November 30, 2028 | WISNIVESKY, JUAN P | reporter.nih.gov |
| Pulmonary Specialist-Health Coach Consult (PuSHCon) model to improve access to specialist consultation and receipt of recommended evidence-based care for vulnerable patients with COPD and asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,516,955 | September 1, 2019 | July 31, 2025 | WILLARD-GRACE, RACHEL | reporter.nih.gov |
| Identifying causal mechanisms of metabolites in family-based association studies of childhood asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,511,779 | September 25, 2025 | June 30, 2027 | LUTZ, SHARON MARIE | reporter.nih.gov |
| Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,511,666 | March 1, 2019 | March 1, 2025 | TEPPER, ROBERT S. | reporter.nih.gov |
| GLP-1R agonist immune targets in lean and obesity-associated asthma | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,491,931 | August 16, 2024 | June 30, 2029 | CAHILL, KATHERINE N | reporter.nih.gov |
| Childhood Allergy and the NeOnatal Environment in St Louis (CANOE-STL) and the Impact of Wheezing Illnesses on Neurocognitive Development of Preschool Children | NIH | Office of the Director, National Institutes of Health | 2025 | $1,488,322 | September 1, 2023 | May 31, 2030 | RIVERA-SPOLJARIC, KATHERINE | reporter.nih.gov |
| Poly-omic Study of Asthma Exacerbations in Diverse Populations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,484,303 | February 1, 2019 | January 31, 2025 | WILLIAMS, KEOKI | reporter.nih.gov |
| Role and Regulation of TSLP in Childhood Allergic Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,477,913 | December 6, 2017 | November 30, 2023 | KHURANA HERSHEY, GURJIT K. | reporter.nih.gov |
| A role for pharmaceutical control of protease-activated receptor-2 for the treatment of asthma | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,476,327 | July 16, 2024 | May 31, 2029 | BOITANO, SCOTT | reporter.nih.gov |
| The influence of asthma on walking in older adults: brain predictors, medication adherence and asthma control | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,475,247 | August 15, 2024 | May 31, 2029 | HOLTZER, ROEE | reporter.nih.gov |
| Phenotypes and Endotypes of Preschool Wheeze | NIH | National Institute of Nursing Research | 2021 to 2023 | $1,465,297 | April 3, 2019 | July 31, 2025 | FITZPATRICK, ANNE MENTRO | reporter.nih.gov |
| Rhinovirus, airway smooth muscle, and mechanisms of irreversible airflow obstruction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,462,824 | June 9, 2023 | March 31, 2027 | KOZIOL-WHITE, CYNTHIA | reporter.nih.gov |
| Atopic dermatitis: mechanisms of disease progression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,439,129 | April 20, 2020 | March 31, 2027 | KHURANA HERSHEY, GURJIT K. | reporter.nih.gov |
| A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,438,456 | January 1, 2019 | December 31, 2023 | RAZ, EYAL | reporter.nih.gov |
| IdeNtifying reSponse defIninG mecHanisms for biological TherapieS in SevereAsthma (INSIGHTS ); assessing the role of CD4-CTLs | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,436,586 | September 20, 2025 | June 30, 2027 | SEUMOIS, GREGORY | reporter.nih.gov |
| Novel nutriceuticals relax airway smooth muscle and decrease inflammation in allergic lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,425,021 | December 1, 2019 | November 30, 2024 | EMALA, CHARLES W | reporter.nih.gov |
| Traffic-Related Ultrafine Particles Disrupt The Resolution Of Lung Inflammation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,424,670 | December 15, 2023 | November 30, 2027 | LEVY, BRUCE D | reporter.nih.gov |
| Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,412,018 | December 2, 2021 | December 31, 2025 | ORTEGA, VICTOR E. | reporter.nih.gov |
| Primary care Implementation and evaluation of Coach McLungs™ an asthma shared decision-making intervention, across a large healthcare system | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,410,086 | September 1, 2021 | July 31, 2026 | TAPP, HAZEL | reporter.nih.gov |
| E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,409,237 | September 1, 2022 | May 31, 2027 | SHARMA, PAWAN | reporter.nih.gov |
| Airway metagenome & metabolome in bronchiolitis and risk of asthma: MARC-35 cohort | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,396,566 | December 1, 2017 | November 30, 2023 | HASEGAWA, KOHEI | reporter.nih.gov |
| The Salton Sea and Children's Health: Assessing Imperial Valley Respiratory Health and the Environment | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,390,302 | July 15, 2018 | April 30, 2024 | FARZAN, SHOHREH F | reporter.nih.gov |
| Telemedicine Enhanced Asthma Management - Uniting Providers (TEAM-UP) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,388,224 | July 15, 2018 | June 30, 2025 | HALTERMAN, JILL S | reporter.nih.gov |
| Impact of Maternal Arsenic Exposure on Offspring's Epigenetic Reprogramming of Allergic Airway Disease | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,381,185 | August 2, 2023 | May 31, 2028 | TANG, WAN-YEE | reporter.nih.gov |
| Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,375,123 | February 1, 2025 | November 30, 2028 | PERA, TONIO | reporter.nih.gov |
| Electric Vehicle Adoption in California: Predictors, Impacts on Local Air Quality and Respiratory Health | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,375,106 | April 20, 2023 | January 31, 2028 | GARCIA, ERIKA | reporter.nih.gov |
| Unique ADP-ribosylating and vacuolating properties of Mycoplasma pneumoniae CARDS toxin trigger airway inflammation and disease progression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,368,330 | March 1, 2019 | February 28, 2026 | KANNAN, THIRUMALAI RENGASAMY | reporter.nih.gov |
| Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and YoungAdults with Asthma (MATCH) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,357,409 | May 1, 2018 | July 31, 2025 | BLAKE, KATHRYN V | reporter.nih.gov |
| Translating an Evidence-based Urban Asthma Program for Rural Adolescents: Testing Effectiveness & Cost-effectiveness and Understanding Factors Associated with Implementation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,355,840 | July 5, 2017 | December 31, 2024 | BRUZZESE, JEAN-MARIE | reporter.nih.gov |
| Multi-omic studies of asthma severity in an African ancestry population | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,350,350 | February 1, 2018 | January 31, 2024 | BARNES, KATHLEEN C | reporter.nih.gov |
| Understanding the Molecular Genetic Mechanisms of Asthma Risk Loci: IL33, IL1RL1, and GSDMB | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,347,477 | January 15, 2018 | February 28, 2023 | GORDON, ERIN D. | reporter.nih.gov |
| Transmembrane Protein 178 as a Novel Endogenous Inhibitory Mechanism in Asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,343,700 | August 15, 2024 | May 31, 2029 | CHIARELLA, SERGIO E | reporter.nih.gov |
| Obesity and Childhood Asthma: The Role of Adipose Tissue | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,341,280 | March 1, 2020 | June 30, 2023 | FORNO, ERICK | reporter.nih.gov |
| FUNGAL PATHOGENESIS OF MODERATE TO SEVERE ASTHMA | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,338,306 | March 23, 2018 | February 29, 2024 | CORRY, DAVID B | reporter.nih.gov |
| Induction of cells and pathways that promote respiratory tolerance in allergic asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,324,768 | September 1, 2019 | August 31, 2025 | AKBARI, OMID | reporter.nih.gov |
| Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,321,378 | April 16, 2020 | November 30, 2021 | CAMARGO, CARLOS ARTURO | reporter.nih.gov |
| Wisconsin Infant Study Cohort (WISC) ECHO Pediatric Follow-Up | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $1,313,759 | September 21, 2016 | May 31, 2025 | GERN, JAMES E. | reporter.nih.gov |
| RVA Breathes: A Richmond City Collaboration to Reduce Pediatric Asthma Disparities | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,302,395 | August 15, 2017 | June 30, 2025 | EVERHART, ROBIN S | reporter.nih.gov |
| Childhood Asthma: Disease Course and Lung Function Trajectories and Air Pollution Exposure | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,300,935 | February 1, 2024 | November 30, 2028 | MATSUI, ELIZABETH C. | reporter.nih.gov |
| Molecular understanding of the GSDMB-regulated innate immune response | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,293,641 | December 15, 2022 | November 30, 2024 | ZHOU, ANNY XIAOBO | reporter.nih.gov |
| Nitric oxide induced soluble guanylate cyclase dysfunction or activation: Implications as a disease indicator or in therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,284,685 | September 15, 2023 | June 30, 2025 | GHOSH, ARNAB | reporter.nih.gov |
| University of Puerto Rico STEM Asthma Awareness Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,277,123 | August 10, 2021 | July 31, 2026 | QUESADA, ORESTES | reporter.nih.gov |
| Driving Environmental Justice: Community Monitoring of Diesel Truck Emissions and Impacts onAsthma Morbidity in Immigrant Communities | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,271,618 | August 6, 2024 | May 31, 2029 | THAKUR, NEETA | reporter.nih.gov |
| Understanding the role of bilevel positive airway pressure (BPAP) in pediatric acute asthma exacerbations: A prospective, randomized, double blind, controlled trial. | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,265,071 | September 20, 2022 | June 30, 2026 | WILSON, PATRICK THOMAS | reporter.nih.gov |
| A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,263,316 | August 20, 2023 | May 31, 2027 | TU, YAPING | reporter.nih.gov |
| Mechanisms of Cytokine-Mediated Integrin Activation and Force Transmission in Airway Smooth Muscle | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,256,953 | April 1, 2024 | March 31, 2029 | SUNDARAM, APARNA BALA | reporter.nih.gov |
| Neurotrophins in the Lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,235,128 | June 1, 2009 | December 31, 2023 | PRAKASH, Y. S. | reporter.nih.gov |
| The nose-lung cross talk in upper respiratory virus infection induced asthma exacerbations | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,218,422 | July 1, 2023 | May 1, 2024 | HUA, XIAOYANG | reporter.nih.gov |
| Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients | NIH | National Institute of Nursing Research | 2021 to 2023 | $1,216,930 | July 20, 2018 | February 28, 2025 | PERRY, TAMARA TAYLOR | reporter.nih.gov |
| Initiators, biomarkers and mechanisms of epithelial dysfunction and immune pathogenesis in chronic rhinosinusitis and aspirin exacerbated respiratory disease (AERD) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,214,468 | February 15, 2018 | January 31, 2024 | SCHLEIMER, ROBERT P | reporter.nih.gov |
| The Differentiation and Function of heterogeneous populations of Allergen-specific Lung-resident Th2 CD4+ memory cells | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,213,156 | February 1, 2024 | December 31, 2028 | PEPPER, MARION | reporter.nih.gov |
| The role of TRAF4 E3 ligase in IL-25-mediated allergic asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,207,500 | March 1, 2020 | February 28, 2025 | LIU, CAINI | reporter.nih.gov |
| Perinatal Dysbiosis, Lung Development and Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,195,681 | June 10, 2020 | May 31, 2024 | LEWKOWICH, IAN PAUL | reporter.nih.gov |
| Structure and mechanism of pendrin and the mutations that cause Pendred's Syndrome | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,192,627 | September 1, 2023 | May 31, 2027 | QUICK, MATTHIAS | reporter.nih.gov |
| S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lung | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,184,606 | April 15, 2024 | January 31, 2028 | RAFFAY, THOMAS MICHAEL | reporter.nih.gov |
| Prenatal control of offspring airway responsiveness | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,180,986 | April 1, 2019 | March 31, 2024 | JACOBY, DAVID B | reporter.nih.gov |
| ECHO Renewal for the INSPIRE Study Cohort | NIH | Office of the Director, National Institutes of Health | 2025 | $1,172,231 | September 1, 2023 | May 31, 2030 | HARTERT, TINA V | reporter.nih.gov |
| Endoplasmic Reticulum Stress Signaling in Allergen-induced Airway Remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,170,000 | January 1, 2015 | October 31, 2024 | ANATHY, VIKAS | reporter.nih.gov |
| Neuroimmune interactions regulate development of allergic inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,164,690 | July 1, 2018 | June 30, 2023 | KUCHROO, VIJAY K. | reporter.nih.gov |
| THE HUMAN INFANT AIRWAY EPITHELIUM AND RECURRENT WHEEZING AFTER RV AND RSV INFECTION | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,164,580 | September 1, 2019 | July 31, 2024 | NINO, GUSTAVO | reporter.nih.gov |
| Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,161,037 | April 1, 2024 | March 31, 2028 | DESHPANDE, DEEPAK A | reporter.nih.gov |
| Nuclear Receptor REV-ERB alpha Role in the Pathophysiology of Allergic Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,160,990 | February 20, 2021 | June 30, 2025 | SUNDAR, ISAAC KIRUBAKARAN | reporter.nih.gov |
| Feelix @ Home: Testing and optimization of a smart stethoscope for home use to monitor changes in lung status of individuals with chronic conditions | NIH | National Heart, Lung, and Blood Institute | 2022 | $1,148,290 | August 1, 2020 | July 31, 2023 | BUSCH-VISHNIAC, ILENE JOY | reporter.nih.gov |
| School-Based Asthma Therapy (SBAT) to Reduce Disparities in Childhood Asthma: Pragmatic Process and Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,143,272 | September 1, 2019 | July 31, 2024 | ARCOLEO, KIMBERLY JOAN | reporter.nih.gov |
| Genetic Control of the SYK Tyrosine-protein Kinase in Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,134,747 | January 22, 2024 | November 30, 2028 | GAO, LI | reporter.nih.gov |
| Mitigation of Exaggerated Smooth Muscle Force with Inhibitors of Integrin Alpha2Beta1 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,130,445 | May 26, 2022 | April 30, 2024 | SUNDARAM, APARNA BALA | reporter.nih.gov |
| Targeting Type-2 mucoinflammatory axis during the resolution of allergic lung inflammation | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,130,392 | January 22, 2024 | October 31, 2028 | SAINI, YOGESH | reporter.nih.gov |
| Regulation of FcεRI function by the MS4A gene cluster | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,124,878 | September 18, 2019 | August 31, 2025 | CRUSE, GLENN PAUL | reporter.nih.gov |
| Mechanisms of Antigen-Induced Tolerance in the Lung | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,120,442 | June 12, 2024 | April 30, 2029 | RAY, ANURADHA | reporter.nih.gov |
| Obesity and Childhood Asthma: The Role of Adipose Tissue | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,116,484 | November 22, 2023 | February 28, 2026 | FORNO, ERICK | reporter.nih.gov |
| Physics of bronchial epithelial unjamming | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,114,810 | August 15, 2019 | April 30, 2024 | FREDBERG, JEFFREY J | reporter.nih.gov |
| Asthma and Technology in Emerging African American Adults (The ATHENA Project) | NIH | National Institute of Nursing Research | 2022 to 2023 | $1,107,171 | September 1, 2021 | December 31, 2023 | BAPTIST, ALAN P. | reporter.nih.gov |
| Mechanistic Study of Inspiratory Training in Childhood Asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,102,720 | July 1, 2023 | March 31, 2028 | LANG, JASON E. | reporter.nih.gov |
| Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,081,849 | October 21, 2020 | February 28, 2025 | MIN, BOOKI | reporter.nih.gov |
| Function and regulation of mucosal associated invariant T cells in the lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,076,286 | November 24, 2021 | June 30, 2023 | YANG, QI | reporter.nih.gov |
| Airway inflammation and fear: elucidating immune mediators and neural substrates | NIH | National Institute of Mental Health | 2024 to 2025 | $1,076,278 | September 1, 2024 | June 30, 2029 | SAH, RENU | reporter.nih.gov |
| BREATHE-BRinging Exercise, Asthma Assessments, TeacHing to Everyone | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,072,906 | September 15, 2023 | August 31, 2027 | FLYNN, SHERYL | reporter.nih.gov |
| CysLT and P2Y Receptors in Lung Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,071,014 | January 1, 2018 | December 31, 2022 | BOYCE, JOSHUA A | reporter.nih.gov |
| Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast cell Activation and Pulmonary Inflammation during Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,059,387 | February 20, 2019 | January 31, 2025 | PARUCHURI, SAILAJA | reporter.nih.gov |
| Exhaled small RNA biomarkers to detect and monitor airway disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,048,432 | January 1, 2021 | December 31, 2023 | SPIVACK, SIMON D | reporter.nih.gov |
| VCSIP2: CCC - Lead Application | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,037,156 | July 15, 2012 | May 31, 2024 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Insulin Resistance, Pre-Diabetes, and Diabetes in Obesity-Associated Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,035,059 | May 15, 2021 | April 30, 2026 | WU, TIANSHI DAVID | reporter.nih.gov |
| Optimizing function-selective ERK1/2 inhibitors for reducing AP-1-mediated airway pathology in asthma. | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,020,046 | June 15, 2023 | May 31, 2025 | SHAPIRO, PAUL S | reporter.nih.gov |
| Nicotine, Airway Smooth Muscle and Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,019,998 | June 5, 2019 | October 31, 2023 | PABELICK, CHRISTINA MARIA | reporter.nih.gov |
| BREATH - Breastfeeding, Early-life Microbiome and Respiratory Health Study | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,013,066 | August 13, 2024 | July 31, 2029 | SHENHAV, LIAT | reporter.nih.gov |
| Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,007,500 | January 11, 2017 | December 31, 2024 | CASOLA, ANTONELLA | reporter.nih.gov |
| Portable Low-Cost Pulmonary Forced Oscillation Technique Device | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $999,887 | September 1, 2024 | August 31, 2026 | LICHTER, PATRICK A | reporter.nih.gov |
| Understanding the role of myeloid cells in ozone-induced airway disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $999,728 | February 1, 2019 | January 31, 2024 | SAINI, YOGESH | reporter.nih.gov |
| Allergen Exposure Reduction as a Disease-Modifying Strategy in Allergen-Sensitized Children with Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $990,900 | September 1, 2021 | August 31, 2026 | GRANT, TORIE | reporter.nih.gov |
| Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $984,054 | May 1, 2021 | April 30, 2027 | HAUPTMAN, MARISSA | reporter.nih.gov |
| Interoceptors controlling airway constriction | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $983,966 | April 1, 2024 | March 31, 2029 | HAN, LIANG | reporter.nih.gov |
| Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $980,417 | September 20, 2022 | July 31, 2027 | SEUMOIS, GREGORY | reporter.nih.gov |
| Investigating the CDC42 pathway as a novel pathway for pediatric non-atopic obesity-related asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $968,933 | February 1, 2019 | July 21, 2023 | RASTOGI, DEEPA | reporter.nih.gov |
| Lung-Resident Memory Th2 cells in Asthma - New Therapeutic Targets | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $965,690 | January 1, 1997 | November 30, 2023 | LUSTER, ANDREW D | reporter.nih.gov |
| IND enabling development of LGM2605 as adjuvant treatment for asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $964,295 | July 18, 2017 | September 30, 2022 | SIELECKI, THAIS MOTRIA | reporter.nih.gov |
| Macrophage Immunometabolism alteration by intense beta agonist therapy. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $959,955 | September 1, 2020 | January 31, 2023 | RAY, ANURADHA | reporter.nih.gov |
| Asthma and Technology in Emerging African American Adults (The ATHENA Project) | NIH | National Institute of Nursing Research | 2024 to 2025 | $952,449 | September 1, 2021 | May 31, 2027 | BAPTIST, ALAN P. | reporter.nih.gov |
| Structure and function of Helicobacter pylori VacA | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $944,680 | May 1, 1996 | November 30, 2024 | COVER, TIMOTHY L | reporter.nih.gov |
| Tocopherol regulation of the development of responsiveness to allergen early in life | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $941,759 | June 23, 2017 | May 31, 2023 | COOK-MILLS, JOAN M | reporter.nih.gov |
| Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $935,793 | August 1, 2019 | June 30, 2024 | PENN, RAYMOND B. | reporter.nih.gov |
| Regulation of airway epithelial cell-mediated inflammation by CRAC channels | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $928,732 | July 1, 2019 | December 31, 2024 | PRAKRIYA, MURALI | reporter.nih.gov |
| PATINA - Precision Administration of Treatment in Neutrophilic severe Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $915,569 | September 23, 2017 | June 30, 2024 | ISRAEL, ELLIOT | reporter.nih.gov |
| Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $915,000 | September 20, 2022 | July 31, 2024 | SEUMOIS, GREGORY | reporter.nih.gov |
| Steroid resistance of airway ILC2s | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $911,771 | May 15, 2018 | April 30, 2024 | ALAM, RAFEUL | reporter.nih.gov |
| Multi-component INTERLUNG intervention to protect lung health in Nepal | NIH | National Institute of Environmental Health Sciences | 2025 | $893,525 | March 19, 2025 | February 28, 2030 | CHECKLEY, WILLIAM | reporter.nih.gov |
| Function and Differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $866,753 | September 8, 2023 | January 31, 2024 | PEPPER, MARION | reporter.nih.gov |
| Sociomarkers to Predict Asthma Control and Emergency Room Visits (SPACER) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $846,641 | January 15, 2021 | August 31, 2026 | PELTZ, ALON | reporter.nih.gov |
| Emulating hypothetical target trials to establish the comparative effectiveness of biologics in asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $834,840 | June 1, 2025 | March 31, 2030 | AKENROYE, AYOBAMI T | reporter.nih.gov |
| IMPACT OF PRENATAL VITAMIN A DEFICIENCY ON CELL FATE ALTERATIONS IN ADULT AIRWAY HYPERRESPONSIVENESS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $827,075 | April 1, 2020 | February 15, 2023 | SUZUKI, MASAKO | reporter.nih.gov |
| The ALOHA trial: Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern | NIH | National Heart, Lung, and Blood Institute | 2021 | $826,083 | September 20, 2021 | August 31, 2022 | MA, JUN | reporter.nih.gov |
| Mechanistic insights into asthma pathogenesis through the integration of asthma genes, risk exposures, and metabolomics | NIH | National Heart, Lung, and Blood Institute | 2021 | $823,032 | May 15, 2018 | April 30, 2023 | LASKY-SU, JESSICA A | reporter.nih.gov |
| Novel Markers of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $822,152 | January 15, 2022 | December 31, 2026 | NAVANANDAN, NIDHYA | reporter.nih.gov |
| TGF-Beta Regulates CFTR-Mediated Airway Smooth Muscle Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $820,800 | February 1, 2021 | January 31, 2026 | KRAMER, ELIZABETH L | reporter.nih.gov |
| The Efficacy of CAMP Air, a Web-based Asthma Intervention, Among Urban Adolescents with Uncontrolled Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 | $819,279 | July 7, 2021 | June 30, 2022 | BRUZZESE, JEAN-MARIE | reporter.nih.gov |
| PrecISE Network: ADAPT (Advancing Severe Asthma Precision Therapy) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $811,032 | September 23, 2017 | June 30, 2025 | CARR, TARA F | reporter.nih.gov |
| Reorganization of the actin cytoskeleton in airway smooth muscle | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $810,000 | December 1, 2011 | March 31, 2025 | TANG, DALE D. | reporter.nih.gov |
| Clinical Centers for the NHLBI's Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) Network (UG1) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $809,743 | September 23, 2017 | June 30, 2025 | GASTON, BENJAMIN | reporter.nih.gov |
| Coping with Asthma through Life Management (CALM) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $807,664 | September 20, 2021 | August 31, 2026 | RILEY, ISARETTA | reporter.nih.gov |
| A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent Exacerbations | NIH | National Heart, Lung, and Blood Institute | 2025 | $806,508 | August 1, 2024 | July 31, 2029 | BROWN, E SHERWOOD | reporter.nih.gov |
| Deciphering respiratory disease mechanisms through integration of genomic and functional data across massive global biobanks | NIH | National Heart, Lung, and Blood Institute | 2025 | $805,921 | September 10, 2025 | June 30, 2030 | MARTIN, ALICIA | reporter.nih.gov |
| Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $805,352 | February 10, 2020 | January 31, 2025 | DEBLEY, JASON S | reporter.nih.gov |
| Treating severe asthma in the small airways with a highly efficient and penetrating inhaled dry powder | NIH | National Heart, Lung, and Blood Institute | 2021 | $802,302 | August 10, 2020 | December 31, 2022 | BEVERLIN II, BRYCE | reporter.nih.gov |
| Improving the analysis and use of contaminated immunoassays: from methods development to implementation | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $802,013 | September 1, 2024 | June 30, 2029 | CHEN, QIXUAN | reporter.nih.gov |
| Miz1: Mechanistic Insights into Endotoxin-Induced Protection Against Allergenic Asthma and Its Therapeutic Potential | NIH | National Heart, Lung, and Blood Institute | 2025 | $801,648 | September 23, 2025 | May 31, 2029 | LIU, JING | reporter.nih.gov |
| Chicago Asthma School-Directed Child-Centered Assessment and Dissemination of Evidence (CASCADE) Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $801,413 | May 5, 2020 | April 30, 2025 | VOLERMAN, ANNA | reporter.nih.gov |
| Chicago Metropolitan Asthma Consortium for severe / exacerbation-prone asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $797,678 | September 23, 2017 | June 30, 2025 | WHITE, STEVEN R | reporter.nih.gov |
| Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS) | NIH | National Heart, Lung, and Blood Institute | 2021 | $794,995 | July 15, 2021 | June 30, 2023 | EAKIN, MICHELLE NUTTALL | reporter.nih.gov |
| A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent Exacerbations | NIH | National Heart, Lung, and Blood Institute | 2024 | $790,698 | August 1, 2024 | July 31, 2025 | BROWN, E SHERWOOD | reporter.nih.gov |
| Epigenome-wide association study of childhood asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $784,641 | January 1, 2017 | December 31, 2022 | VIJAYANAND, PANDURANGAN | reporter.nih.gov |
| Radon Asthma Intervention Trial (ROME) | NIH | National Heart, Lung, and Blood Institute | 2025 | $784,318 | September 11, 2025 | August 31, 2030 | PHIPATANAKUL, WANDA | reporter.nih.gov |
| Patient Entered Data for Clinical Decision Support to Personalize Pediatric Asthma Management | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $784,068 | June 15, 2020 | May 31, 2025 | ROSS, MINDY K | reporter.nih.gov |
| Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $780,802 | July 1, 2023 | June 30, 2026 | ARNOLD, DONALD HAYES | reporter.nih.gov |
| Early life hyperoxic exposure, lung innate immune responses, bronchopulmonary dysplasia and asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $780,000 | February 1, 2018 | January 31, 2024 | POPOVA, ANTONIA PETROVA | reporter.nih.gov |
| Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $779,980 | August 1, 2022 | July 31, 2027 | FOER, DINAH | reporter.nih.gov |
| Using Computational Approaches to Optimize Asthma Care Management | NIH | National Heart, Lung, and Blood Institute | 2021 | $775,715 | August 1, 2018 | June 30, 2023 | LUO, GANG | reporter.nih.gov |
| Mentoring patient-oriented researchers in inflammatory airway disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $774,776 | July 1, 2022 | June 30, 2027 | DOHERTY, TAYLOR A | reporter.nih.gov |
| Type-2 or Not Type-2: That is the (Therapeutic) Question | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $773,392 | September 23, 2017 | June 30, 2025 | WENZEL, SALLY E | reporter.nih.gov |
| Role of Semaphorin 4A in Allergic Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $772,500 | August 1, 2018 | July 31, 2024 | KEEGAN, ACHSAH D. | reporter.nih.gov |
| Promoting Asthma Guidelines and Management through Technology-Based Intervention and Care Coordination in Clinics and Schools (PRAGMATIC-S) | NIH | National Heart, Lung, and Blood Institute | 2025 | $771,750 | September 15, 2025 | June 30, 2030 | REZNIK, MARINA | reporter.nih.gov |
| Advanced Statistical Methods for Microbiome Data Analysis | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $768,705 | September 1, 2020 | August 31, 2025 | TANG, ZHENGZHENG | reporter.nih.gov |
| The function of MrgprC11+ vagal sensory neurons in the airway | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $763,265 | April 1, 2018 | March 31, 2024 | HAN, LIANG | reporter.nih.gov |
| Metformin IN Asthma for overweight and obese individuals (MINA) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $758,479 | September 18, 2023 | August 31, 2027 | MCCORMACK, MEREDITH C | reporter.nih.gov |
| Integrative network-based analysis of multi-omics data to elucidate the molecular connection between asthma and COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $756,000 | July 18, 2020 | June 30, 2026 | HALU, ARDA | reporter.nih.gov |
| Defining the role of tuft cells in allergic airway disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $755,352 | September 10, 2022 | August 31, 2027 | KOTAS, MAYA | reporter.nih.gov |
| San Diego Team Asthma Management using Phenotypes (STAMP) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $755,007 | September 23, 2017 | June 30, 2024 | AKUTHOTA, PRAVEEN | reporter.nih.gov |
| Early Life Predictors of Airway to Lung Dysanapsis | NIH | National Heart, Lung, and Blood Institute | 2024 | $753,018 | September 17, 2024 | August 31, 2025 | LOVINSKY-DESIR, STEPHANIE | reporter.nih.gov |
| Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD | NIH | National Heart, Lung, and Blood Institute | 2021 | $751,239 | February 1, 2019 | August 31, 2021 | ORTEGA, VICTOR E. | reporter.nih.gov |
| Technology-Enhanced Asthma Care in Children at Clinic and Home (TEACCCH) Study | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $747,406 | March 1, 2022 | January 31, 2027 | KAN, KRISTIN | reporter.nih.gov |
| Mechanistic Investigation of Gut Mycobiota in the Regulation of Lung Immunity and Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $747,000 | July 1, 2023 | June 30, 2026 | LI, XIN | reporter.nih.gov |
| Pollution Intervention to Impact Kids Asthma Study (PIKAS) | NIH | National Institute of Environmental Health Sciences | 2025 | $744,737 | September 10, 2025 | June 30, 2030 | ROSSER, FRANZISKA | reporter.nih.gov |
| Sputum Microbial Markers of Type 2-Low Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $742,420 | June 7, 2017 | May 31, 2023 | HUANG, YVONNE JEAN | reporter.nih.gov |
| Evaluating a mobile health tool to improve management of pediatric acute respiratory illness in Uganda | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $742,280 | September 15, 2022 | November 30, 2027 | ELLINGTON, LAURA E | reporter.nih.gov |
| Heme allocation and disruptions in asthma and the failing heart | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $742,020 | January 1, 2022 | December 31, 2025 | SWEENY, ELIZABETH A. | reporter.nih.gov |
| LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics | NIH | National Heart, Lung, and Blood Institute | 2022 | $741,557 | May 1, 2022 | April 30, 2023 | HOLGUIN, FERNANDO | reporter.nih.gov |
| ILC2s as drivers of lung dysfunction in response to early-life inflammation | NIH | National Heart, Lung, and Blood Institute | 2025 | $740,709 | August 1, 2025 | May 31, 2029 | BEAUDIN, ANNA E | reporter.nih.gov |
| Adverse Effects of Neonatal CPAP on Lung Development | NIH | National Heart, Lung, and Blood Institute | 2025 | $740,196 | June 1, 2025 | March 31, 2029 | MACFARLANE, PETER | reporter.nih.gov |
| University of Kansas' Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE) Clinical Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $739,659 | September 17, 2019 | June 30, 2025 | CASTRO, MARIO | reporter.nih.gov |
| Intravenous Magnesium: Prompt Use for Asthma in Children Treated in the Emergency Department (IMPACT-ED) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $737,920 | April 1, 2022 | September 30, 2024 | JOHNSON, MICHAEL DAVID | reporter.nih.gov |
| Gender and Asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $737,299 | December 1, 2023 | November 30, 2027 | ZEIN, JOE | reporter.nih.gov |
| Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $735,011 | September 23, 2017 | June 30, 2024 | WECHSLER, MICHAEL E | reporter.nih.gov |
| Mitochondrial Mechanisms in Asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $732,225 | August 1, 2025 | April 30, 2030 | ERZURUM, SERPIL C. | reporter.nih.gov |
| Improving Medication Adherence using an Adaptive mHealth Intervention in Adolescents with Asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $731,130 | September 19, 2025 | June 30, 2030 | RAMSEY, RACHELLE R. | reporter.nih.gov |
| Adipocyte-Eosinophil Communication and Its Role in Regulation of Airway Function | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $730,392 | June 17, 2025 | May 31, 2030 | BERDNIKOVS, SERGEJS | reporter.nih.gov |
| Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children | NIH | National Heart, Lung, and Blood Institute | 2021 | $729,775 | May 1, 2017 | April 30, 2024 | SEIBOLD, MAX A | reporter.nih.gov |
| The Great Lakes PrecISE Partnership | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $729,376 | September 23, 2017 | June 30, 2024 | DENLINGER, LOREN C | reporter.nih.gov |
| Optimizing a Sensor-Enabled mHealth Intervention for Adolescents with Suboptimal Asthma Control | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $727,641 | September 15, 2023 | August 31, 2027 | CUSHING, CHRISTOPHER C | reporter.nih.gov |
| The Dallas Asthma Brain and Cognition Study (Dallas ABC Study) | NIH | National Heart, Lung, and Blood Institute | 2021 | $725,468 | July 15, 2018 | May 31, 2025 | RITZ, THOMAS EKKEHARD | reporter.nih.gov |
| Resolution of Epithelial Cell Hyperplasia in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 | $724,538 | July 1, 2003 | May 31, 2024 | TESFAIGZI, YOHANNES | reporter.nih.gov |
| Phenotyping Asthma for Bronchial Thermoplasty: Airway Smooth Muscle Structure and Function | NIH | National Heart, Lung, and Blood Institute | 2021 | $723,611 | July 1, 2017 | June 30, 2025 | SUTER, MELISSA J | reporter.nih.gov |
| Discovering the Immunologic Mechanism of Ascaris-induced Allergic Airway Disease. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $723,215 | February 20, 2020 | October 31, 2025 | WEATHERHEAD, JILL ELIZABETH | reporter.nih.gov |
| ENDS aerosol particle deposition, in utero exposures and children's respiratory health effects (ENDURE) | NIH | National Institute of Environmental Health Sciences | 2025 | $720,855 | March 13, 2025 | February 29, 2028 | COMMODORE, SARAH | reporter.nih.gov |
| lncRNA Control of Airway Epithelial Cell Responses to Type 2 Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $720,795 | January 1, 2019 | January 31, 2022 | WILLIAMS, ADAM | reporter.nih.gov |
| A culturally tailored, scalable asthma intervention for Mexican American children | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $713,250 | June 15, 2022 | May 31, 2026 | MATSUI, ELIZABETH C. | reporter.nih.gov |
| Integrative metabolomic characterization of ADHD and asthma comorbidity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $712,800 | August 1, 2020 | June 30, 2026 | CHU, SU HEE | reporter.nih.gov |
| The SIP Study: Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children | NIH | National Heart, Lung, and Blood Institute | 2021 | $706,834 | July 1, 2021 | June 30, 2022 | KAISER, SUNITHA VEMULA | reporter.nih.gov |
| Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools | NIH | National Institute on Minority Health and Health Disparities | 2021 | $704,713 | September 25, 2017 | May 31, 2024 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Multiple long-term environmental exposures and incidence of asthma | NIH | National Institute of Environmental Health Sciences | 2025 | $704,105 | May 1, 2025 | February 28, 2030 | HART, JAIME ELIZABETH | reporter.nih.gov |
| Function and Regulation of Airway Mucin Glycosylation | NIH | National Heart, Lung, and Blood Institute | 2025 | $702,308 | September 1, 2025 | June 30, 2029 | EVANS, CHRISTOPHER M | reporter.nih.gov |
| Treating Respiratory Emergencies in Children (T-RECS) Feasibility Study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $701,431 | June 1, 2023 | May 31, 2025 | HANSEN, MATTHEW LEE | reporter.nih.gov |
| Integrative Longitudinal Genomics of Maternal Asthma-Preeclampsia Overlap and Risk of Childhood Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $699,840 | January 3, 2020 | December 31, 2025 | MIRZAKHANI, HOOMAN | reporter.nih.gov |
| Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $699,063 | September 23, 2017 | June 30, 2024 | FAHY, JOHN V | reporter.nih.gov |
| Microbial-derived metabolites potentiate airway hyperresponsiveness in obesity-associated asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $696,473 | July 20, 2025 | April 30, 2029 | GELHAUS, STACY LYNN | reporter.nih.gov |
| Asthma Link: School Supervised Therapy to Improve Medication Adherence in Children with Poorly Controlled Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $691,753 | February 16, 2020 | January 31, 2026 | TRIVEDI, MICHELLE | reporter.nih.gov |
| Effect of the Housing and Urban Development’s Smokefree Public Housing Rule on Air Quality and Health in the District of Columbia | NIH | National Cancer Institute | 2021 | $691,408 | December 15, 2018 | November 30, 2023 | BERNAT, DEBRA H | reporter.nih.gov |
| Social Determinants of Symptoms in Preschool Children with Recurrent Wheezing | NIH | National Heart, Lung, and Blood Institute | 2025 | $690,473 | September 8, 2025 | May 31, 2029 | FITZPATRICK, ANNE MENTRO | reporter.nih.gov |
| Extreme Weather Impacts on Children's Acute and Chronic Health Outcomes: A Multi-Site Study with Evaluation of Vulnerabilities | NIH | National Institute of Environmental Health Sciences | 2024 | $687,343 | September 16, 2024 | August 31, 2025 | DE ROOS, ANNECLAIRE J | reporter.nih.gov |
| Long-term Phenotypic Alteration in the Lung Epithelium Following Early-life RSV Infection | NIH | National Heart, Lung, and Blood Institute | 2025 | $680,562 | September 15, 2025 | June 30, 2030 | FONSECA AGUILAR, WENDY | reporter.nih.gov |
| Synthesizing Trial and Real-world Data on the Use of Biologics in Patients with Severe Asthma | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $677,279 | December 26, 2020 | December 31, 2025 | AKENROYE, AYOBAMI T | reporter.nih.gov |
| EQUITABLE: Equity in Treatment for Asthma Between Latinos and Whites | NIH | National Heart, Lung, and Blood Institute | 2025 | $673,581 | March 1, 2025 | December 31, 2028 | HEINTZMAN, JOHN D. | reporter.nih.gov |
| Genetic mechanisms underlying maladaptive respiratory responses to air pollution | NIH | National Institute of Environmental Health Sciences | 2025 | $671,165 | January 1, 2025 | October 31, 2029 | KELADA, SAMIR | reporter.nih.gov |
| Airway inflammation and fear: neuroimmune mechanisms and forebrain circuits | NIH | National Institute of Mental Health | 2022 to 2023 | $670,850 | August 8, 2022 | July 31, 2025 | SAH, RENU | reporter.nih.gov |
| Treatment Phenotypes for Adolescents with Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $669,772 | February 5, 2020 | April 30, 2025 | DE KEYSER, HEATHER | reporter.nih.gov |
| Immunopathology of Indirect Airway Hyperresponsiveness in Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $665,490 | January 18, 2017 | June 30, 2027 | HALLSTRAND, TEAL S. | reporter.nih.gov |
| Integrating the genome, metabolome, and microbiome for childhood asthma: Risk and endotypes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $663,023 | March 1, 2021 | February 28, 2026 | ZHU, ZHAOZHONG | reporter.nih.gov |
| The Role of Lung Megakaryocytes in Airway Disease after Neonatal Hyperoxia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $648,564 | April 1, 2022 | March 31, 2027 | DYLAG, ANDREW MICHAEL | reporter.nih.gov |
| The effect of SARS-CoV-2 on the susceptibility of respiratory outcomes in a Puerto Rican Birth Cohort | NIH | National Heart, Lung, and Blood Institute | 2021 | $646,280 | September 20, 2021 | July 31, 2024 | SHEPPARD, DEAN | reporter.nih.gov |
| Chronic outdoor air pollution, airway epithelial "omics" and asthma exacerbations in children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $641,192 | August 15, 2021 | June 30, 2025 | ROSSER, FRANZISKA | reporter.nih.gov |
| Clinical prediction and epigenetic regulation of asthma and rhinitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $638,879 | February 10, 2021 | September 1, 2023 | WANG, ALBERTA L. | reporter.nih.gov |
| Targeting the stromal niche for tissue-resident lymphocytes in asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $636,843 | May 1, 2025 | February 28, 2029 | PENG, TIEN | reporter.nih.gov |
| CEBPD-Mediated Mechanisms of Glucocorticoid Insensitivity in Severe Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 | $632,844 | April 1, 2017 | March 31, 2023 | HIMES, BLANCA E | reporter.nih.gov |
| Genetics of Asthma Sub-Phenotypes Impact Gene Regulation in Cell-Specific Patterns | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $628,128 | August 15, 2020 | July 31, 2025 | SCHOETTLER, NATHAN R | reporter.nih.gov |
| Evaluation of radon progeny and air pollution effects in asthma | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $622,620 | August 11, 2023 | July 31, 2028 | BANZON, TINA | reporter.nih.gov |
| MicroRNAs in Airway Smooth Muscle Function and Asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $616,814 | January 15, 2025 | November 30, 2028 | LU, QUAN | reporter.nih.gov |
| Eosinophils as Effectors of Antibacterial Immunity in the Lungs | NIH | National Heart, Lung, and Blood Institute | 2024 | $615,455 | September 1, 2024 | June 30, 2028 | SAMARASINGHE, AMALI | reporter.nih.gov |
| Aryl hydrocarbon receptor signaling in Airway Inflammation | NIH | National Heart, Lung, and Blood Institute | 2024 | $613,934 | July 19, 2024 | May 31, 2028 | VENKATACHALEM, SATHISH | reporter.nih.gov |
| Eosinophils as Effectors of Antibacterial Immunity in the Lungs | NIH | National Heart, Lung, and Blood Institute | 2025 | $613,501 | September 1, 2024 | June 30, 2028 | SAMARASINGHE, AMALI E | reporter.nih.gov |
| Aryl hydrocarbon receptor signaling in Airway Inflammation | NIH | National Heart, Lung, and Blood Institute | 2025 | $607,292 | July 19, 2024 | May 31, 2028 | VENKATACHALEM, SATHISH | reporter.nih.gov |
| Mentoring Research in Precision Medicine for Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $604,965 | April 28, 2017 | March 31, 2027 | WOODRUFF, PRESCOTT G | reporter.nih.gov |
| Translating an Efficacious Illness Management Intervention for African American Youth with Poorly Controlled Asthma to Real World Settings | NIH | National Heart, Lung, and Blood Institute | 2021 | $600,589 | August 20, 2017 | June 30, 2024 | ELLIS, DEBORAH A. | reporter.nih.gov |
| Novel Integrative Analysis of Microbiome and Host Genetics in Childhood Asthma Research | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $597,904 | June 17, 2025 | May 31, 2030 | CHEN, GUANHUA | reporter.nih.gov |
| Long-term impact of persistent parainfluenza virus infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $596,115 | August 1, 2025 | July 31, 2030 | LOPEZ, CAROLINA B. | reporter.nih.gov |
| The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $592,920 | June 19, 2019 | July 31, 2024 | BUCHHEIT, KATHLEEN MARY | reporter.nih.gov |
| Effectiveness of Low-dose Theophylline for the Management of biomass-associated COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $590,723 | July 15, 2019 | June 30, 2025 | SIDDHARTHAN, TRISHUL | reporter.nih.gov |
| Study the role of ICOS on murine and human ILC2s | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $590,711 | June 11, 2025 | May 31, 2030 | AKBARI, OMID | reporter.nih.gov |
| NOVEL DIAGNOSTIC FOR MANAGING ASTHMA AT POINT OF CARE | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $575,872 | September 1, 2024 | July 31, 2027 | SVAROVSKY, SERGEI A | reporter.nih.gov |
| Data Integration Methods for Environmental Exposures with Applications to Air Pollution and Asthma Morbidity | NIH | National Institute of Environmental Health Sciences | 2021 | $575,611 | May 28, 2021 | January 31, 2023 | CHANG, HOWARD H | reporter.nih.gov |
| Child Asthma Exacerbation: Role of Caregiver Risk Beliefs | NIH | National Heart, Lung, and Blood Institute | 2021 | $575,496 | September 1, 2018 | June 30, 2023 | WATERS, ERIKA A | reporter.nih.gov |
| Cellular and Molecular Mechanisms of the Pathogenesis of Aspirin Exacerbated Respiratory Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $569,084 | July 1, 2019 | June 30, 2024 | STEVENS, WHITNEY W | reporter.nih.gov |
| SCH: Pennsylvania Asthma-COPD Syndromic Surveillance (PASS) | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $568,292 | July 6, 2024 | April 30, 2028 | CHOI, HYUNOK | reporter.nih.gov |
| Mentoring in Patient-Oriented Research on Asthma and the Indoor Environment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $567,009 | February 1, 2015 | February 29, 2024 | MATSUI, ELIZABETH C. | reporter.nih.gov |
| Assessing Airway Smooth Muscle Tone in Asthma with Endobronchial Optical Coherence Tomography | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $567,000 | August 1, 2019 | July 31, 2025 | ADAMS, DAVID C | reporter.nih.gov |
| Early Administration of Steroids in the Ambulance Setting: An Observational Design Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $565,944 | April 1, 2020 | March 31, 2025 | FISHE, JENNIFER NOEL | reporter.nih.gov |
| Long-term alteration of the airway epithelium after early life RSV infection | NIH | National Heart, Lung, and Blood Institute | 2024 | $565,834 | September 9, 2024 | August 31, 2025 | FONSECA AGUILAR, WENDY | reporter.nih.gov |
| Mitigation of Exaggerated Smooth Muscle Force with Inhibitors of Integrin Alpha2Beta1 | NIH | National Heart, Lung, and Blood Institute | 2024 | $565,171 | May 26, 2022 | July 31, 2025 | SUNDARAM, APARNA BALA | reporter.nih.gov |
| Mechanogenomics of the asthmatic airway epithelium | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $564,012 | August 1, 2023 | July 31, 2028 | DE MARZIO, MARGHERITA | reporter.nih.gov |
| Role of novel SphK1 inhibitor, PF543 in therapy of Bronchopulmonary dysplasia and Airway remodeling | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $563,068 | August 15, 2018 | May 31, 2024 | HARIJITH, ANANTHA | reporter.nih.gov |
| Obesity dysregulates immune and metabolic status in asthma and alters infection susceptibility. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $560,844 | December 14, 2018 | November 30, 2023 | HENRICKSON, SARAH E | reporter.nih.gov |
| Identifying Genetic and Epigenetic Risk Factors Regulating Gene Expression for Childhood Asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $558,232 | August 5, 2020 | April 30, 2026 | KIM, SOYEON | reporter.nih.gov |
| Gender-specific effects of puberty on airway epithelial differentiation in asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $557,280 | August 15, 2019 | July 31, 2024 | CHIARELLA, SERGIO E | reporter.nih.gov |
| Using technology-assisted stepped-care interventions to improve adherence in adolescents with asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $546,271 | August 15, 2019 | July 31, 2024 | RAMSEY, RACHELLE R. | reporter.nih.gov |
| Functional Diversity of Compartmentalized Calcium Signaling in Airway Smooth Muscle | NIH | National Heart, Lung, and Blood Institute | 2021 | $541,789 | December 15, 2017 | November 30, 2023 | DESHPANDE, DEEPAK A | reporter.nih.gov |
| The effect of early-life nasal colonization with Lactobacillus on the development of the local immune response and the later onset of recurrent wheeze, childhood asthma, and allergic rhinitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $538,393 | August 15, 2019 | July 31, 2025 | ROSAS-SALAZAR, CHRISTIAN | reporter.nih.gov |
| Pathophysiology of Voice Disorders due to Combination Inhaled Corticosteroids in Asthma | NIH | National Institute on Deafness and Other Communication Disorders | 2021 | $534,766 | May 14, 2018 | April 30, 2023 | TANNER, KRISTINE MARIE | reporter.nih.gov |
| Multi-Omic Endotyping of Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $534,600 | May 1, 2019 | October 31, 2024 | KELLY, RACHEL SABINE | reporter.nih.gov |
| Personalized Approach To Habits-Sleep (PATH-S), an app to improve sleep for Black teens (ages 14-17) with asthma | NIH | National Heart, Lung, and Blood Institute | 2024 | $534,119 | July 10, 2024 | July 9, 2025 | TWOMBLY, ERIC CHARLES | reporter.nih.gov |
| Incentive-based Mobile Health Adherence Intervention for High Risk Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $534,100 | February 1, 2019 | September 30, 2024 | KENYON, CHEN COLLIN | reporter.nih.gov |
| Molecular understanding of the GSDMB-regulated innate immune response | NIH | National Heart, Lung, and Blood Institute | 2025 | $530,529 | December 15, 2022 | November 30, 2026 | ZHOU, ANNY XIAOBO | reporter.nih.gov |
| Clock Gene Control of Viral Infection and Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 | $527,404 | December 15, 2016 | November 30, 2023 | HASPEL, JEFFREY ADAM | reporter.nih.gov |
| Addressing differential performance by socioeconomic status in Artificial Intelligence (AI) models for childhood asthma | NIH | National Heart, Lung, and Blood Institute | 2025 | $526,890 | September 1, 2025 | June 30, 2029 | JUHN, YOUNG J | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Wisconsin-Madison | Madison, WI | 17 | $87.3 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 45 | $62.3 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 30 | $38.8 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 11 | $34 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 23 | $31.1 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 21 | $31 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 23 | $30 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 29 | $29.5 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 15 | $28.5 million | 0 | $0 |
| Rho Federal Systems Division, Inc. | Durham, NC | 1 | $28.2 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 26 | $26.9 million | 0 | $0 |
| University of Washington | Seattle, WA | 12 | $26.2 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 16 | $25.8 million | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 8 | $23.3 million | 0 | $0 |
| National Jewish Health | Denver, CO | 14 | $22.3 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 10 | $21.7 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 6 | $21.4 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 18 | $19.3 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 8 | $18.7 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 14 | $18.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 11 | $17.3 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 5 | $17.1 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 18 | $15.8 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 16 | $14.8 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 6 | $13.9 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 10 | $13.7 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 5 | $13.5 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 9 | $13.1 million | 0 | $0 |
| Washington University | Saint Louis, MO | 10 | $12.8 million | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 8 | $12.2 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 12 | $11.6 million | 0 | $0 |
| University of Vermont & ST Agric College | Burlington, VT | 7 | $11.2 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 7 | $10.3 million | 0 | $0 |
| University of California at Davis | Davis, CA | 7 | $9.8 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 7 | $9.7 million | 0 | $0 |
| Duke University | Durham, NC | 7 | $9.2 million | 0 | $0 |
| University of Chicago | Chicago, IL | 12 | $9.2 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 10 | $9.1 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 8 | $8.4 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 6 | $8.1 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 7 | $7.7 million | 0 | $0 |
| University of Florida | Gainesville, FL | 5 | $7.7 million | 0 | $0 |
| University of Rochester | Rochester, NY | 5 | $7.6 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 5 | $7.1 million | 0 | $0 |
| Harvard Pilgrim Health Care, Inc. | Canton, MA | 3 | $6.9 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 2 | $6.6 million | 0 | $0 |
| Emory University | Atlanta, GA | 7 | $5.8 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 5 | $5.7 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 7 | $5.4 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 5 | $5.4 million | 0 | $0 |
| Children's Mercy Hosp (kansas City, Mo) | Kansas City, MO | 3 | $5.1 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 8 | $5.1 million | 0 | $0 |
| Indiana University | Bloomington, IN | 4 | $4.4 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 2 | $4.2 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 4 | $4 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 6 | $4 million | 0 | $0 |
| Wayne State University | Detroit, MI | 3 | $3.8 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 7 | $3.7 million | 0 | $0 |
| Henry Ford Health System | Detroit, MI | 3 | $3.6 million | 0 | $0 |
| University of South Florida | Tampa, FL | 5 | $3.5 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 2 | $3.5 million | 0 | $0 |
| Yale University | New Haven, CT | 4 | $3.4 million | 0 | $0 |
| Raesedo, LLC | Tucson, AZ | 1 | $3.4 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 3 | $3.4 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 4 | $3.3 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 3 | $3.1 million | 0 | $0 |
| Raft Pharmaceuticals, LLC | San Diego, CA | 1 | $3 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 3 | $3 million | 0 | $0 |
| University of Massachusetts Amherst | Amherst, MA | 1 | $3 million | 0 | $0 |
| Indoor Biotechnologies | Charlottesville, VA | 1 | $3 million | 0 | $0 |
| Albany Medical College | Albany, NY | 4 | $3 million | 0 | $0 |
| Virtici, LLC | Seattle, WA | 1 | $3 million | 0 | $0 |
| George Washington University | Washington, DC | 3 | $2.9 million | 0 | $0 |
| Siolta Therapeutics, Inc. | San Carlos, CA | 1 | $2.9 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 2 | $2.8 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 4 | $2.7 million | 0 | $0 |
| San Diego Biomedical Research Institute | San Diego, CA | 3 | $2.6 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 2 | $2.5 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 4 | $2.5 million | 0 | $0 |
| Rutgers Biomedical/health Sciences-Rbhs | New Brunswick, NJ | 1 | $2.5 million | 0 | $0 |
| Aeon Respire, Inc. | Newbury Park, CA | 1 | $2.5 million | 0 | $0 |
| La Jolla Institute for Immunology | La Jolla, CA | 5 | $2.4 million | 0 | $0 |
| North Dakota State University Fargo | Fargo, ND | 2 | $2.4 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 3 | $2.4 million | 0 | $0 |
| Allerdia INC | Los Angeles, CA | 2 | $2.4 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 3 | $2.3 million | 0 | $0 |
| Brown University | Providence, RI | 1 | $2.3 million | 0 | $0 |
| Loyola University Chicago | Maywood, IL | 3 | $2.3 million | 0 | $0 |
| Parion Sciences, Inc. | Durham, NC | 1 | $2.3 million | 0 | $0 |
| Parmedics, Inc. | Temecula, CA | 3 | $2.3 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 1 | $2.2 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 3 | $2.2 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 2 | $2.1 million | 0 | $0 |
| J. Craig Venter Institute, Inc. | La Jolla, CA | 1 | $2 million | 0 | $0 |
| Nupeak Therapeutics, Inc. | Saint Louis, MO | 1 | $2 million | 0 | $0 |
| Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center | Torrance, CA | 2 | $2 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 2 | $2 million | 0 | $0 |
| University of Maryland, College Park | College Park, MD | 3 | $2 million | 0 | $0 |
| Arkansas Children's Hospital Res Inst | Little Rock, AR | 3 | $2 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 1 | $2 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 338 | $207,653,355 | 0 | $0 |
| 2024 | 368 | $219,913,789 | 0 | $0 |
| 2023 | 370 | $225,167,294 | 0 | $0 |
| 2022 | 381 | $238,119,638 | 0 | $0 |
| 2021 | 418 | $247,820,123 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.